Processing 00000000.tx.1: Hyperglycemia-Induced Apoptosis in Human Umbilical Vein Endothelial Cells Inhibition by the AMP-Activated Protein Kinase Activation Yasuo Ido1, David Carling2, and Neil Ruderman1 1 Boston Medical Center, EBRC 820, Diabetes & Metabolism Unit, Section of Endocrinology and Departments of Medicine and Physiology, Boston University School of Medicine, Boston, Massachusetts 2 Cellular Stress Group, MRC Clinical Sciences Center, Imperial College School of Medicine, London, U.K.  

Phrase: "Hyperglycemia-Induced Apoptosis in Human Umbilical Vein Endothelial Cells Inhibition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   761   C3156636:endothelial cell apoptosis [Cell Function]
   757   C1512772:Apoptosis Inhibition [Cell Function]
   739   C0162638:Apoptosis [Cell Function]

Phrase: "by the AMP-Activated Protein Kinase Activation Yasuo Ido1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C1416433:IDO1 [Gene or Genome]
   795   C2697654:IDO1 [Gene or Genome]
   710   C2350345:AMP-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "David Carling2,"

Phrase: "and"

Phrase: "Neil Ruderman1 1 Boston Medical Center,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   827   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   799   C0006037:Boston [Geographic Area]
   799   C0205099:Center [Spatial Concept]
   799   C0205476:Medical [Functional Concept]

Phrase: "EBRC 820,"

Phrase: "Diabetes & Metabolism Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439148:Unit [Quantitative Concept]
   827   C1519795:Unit [Quantitative Concept]
   827   C1704753:Unit [Manufactured Object]
   827   C1880519:Unit [Quantitative Concept]

Phrase: "Section of Endocrinology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205155:Section [Spatial Concept]
   790   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   790   C1522472:Section [Substance]
   790   C1552923:Section [Quantitative Concept]
   790   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "Departments of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Physiology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "Boston University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts 2 Cellular Stress Group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]

Phrase: "MRC Clinical Sciences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1516630:Clinical Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]

Phrase: "Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: ","

Phrase: "Imperial College School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.2: ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Apoptosis has been observed in vascular cells, nerve, and myocardium of diabetic humans and experimental animals, although whether it contributes to or is a marker of complications in these tissues is unclear. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "observed in vascular cells,"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   783   C0005773:Blood Cells [Cell]
   775 E C2328697:Hemal cell [Cell]
   770   C0005847:vascular [Body Part, Organ, or Organ Component]
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C1558950:VASCULAR [Finding]
   770   C1801960:Vascular [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   715 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   715 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "nerve,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0027740:Nerve [Tissue]
  1000   C0027757:NERVE [Tissue]
  1000   C1280541:Nerve [Body Part, Organ, or Organ Component]
   944 E C0599851:Neural [Functional Concept]
   928 E C0027769:nervy [Sign or Symptom]

Phrase: "and"

Phrase: "myocardium of diabetic humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027061:Myocardium [Tissue]

Phrase: "and"

Phrase: "experimental animals,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0003064:experimental animal [Animal]
   861   C0003062:Animals [Animal]
   861   C1517586:Experimental [Qualitative Concept]

Phrase: "although"

Phrase: "whether"

Phrase: "it"

Phrase: "contributes to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1880177:Contribute [Activity]

Phrase: "or"

Phrase: "is"

Phrase: "a marker of complications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005516:Marker [Clinical Attribute]

Phrase: "in these tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.3: Previous studies have shown that incubation of human umbilical vein endothelial cells (HUVECs) with 30 vs. 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that incubation of human umbilical vein endothelial cells (HUVECs)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   703   C3179121:Human Umbilical Vein Endothelial Cells [Cell]

Phrase: "with 30"

Phrase: "vs."
Processing 00000000.tx.4: 5 mmol/l glucose for 72 h causes a significant increase in apoptosis, possibly related to an increase in oxidative stress. 

Phrase: "5 mmol/l glucose for 72 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a significant increase in apoptosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "related to an increase"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439849:Related [Qualitative Concept]
   770   C0442805:Increase [Functional Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "in oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.5: We report here that this increase in apoptosis (assessed morphologically by TdT-mediated dUTP nick- end labeling staining) is preceded (24 h of incubation) by inhibition of fatty acid oxidation, by increases in diacylglycerol synthesis, the concentration of malonyl CoA, and caspase-3 activity, and by decreases in mitochondrial membrane potential and cellular ATP content. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "that"

Phrase: "this increase in apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "("

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "morphologically by TdT-mediated dUTP nick- end labeling staining"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0057470:dUTP [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0444930:End [Spatial Concept]
   742   C0487602:Staining [Laboratory Procedure]
   742   C1167624:Labeling [Mental Process]
   742   C1704680:Staining [Finding]
   742   C1947902:Labeling [Manufactured Object]
   742   C2746065:End [Temporal Concept]
   742   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: ")"

Phrase: "is"

Phrase: "preceded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:preceded [Temporal Concept]

Phrase: "(24 h of incubation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "by inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of fatty acid oxidation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "by increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "in diacylglycerol synthesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157334:diacylglycerol synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "the concentration of malonyl CoA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "caspase-3 activity,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and by decreases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0547047:decreases [Quantitative Concept]
   790   C1515981:And [Idea or Concept]
   756 E C0392756:Decrease [Qualitative Concept]

Phrase: "in mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "cellular ATP content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.6: In addition, the phosphorylation of Akt in the presence of 150 U/ml insulin was impaired. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 150 U/ml insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "impaired."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.7: No increases in ceramide content or its de novo synthesis were observed. 

Phrase: "No increases in ceramide content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "or"

Phrase: "its de novo synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   734   C1515568:de novo [Idea or Concept]

Phrase: "were"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.8: AMP-activated protein kinase (AMPK) activity was not diminished; 

Phrase: "AMP-activated protein kinase (AMPK) activity"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C1150593:AMP-activated protein kinase activity [Molecular Function]
   924   C1325136:AMP-activated kinase activity [Molecular Function]
   884   C1150527:protein kinase activity [Molecular Function]
   865 E C2261495:protein phosphokinase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C2350345:AMP-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           AMP-Activated Kinase
   708   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.9: however, incubation with the AMPK activator 5-aminoimidazole-4-carboxamide-riboside increased AMPK activity twofold and completely prevented all of these changes. 

Phrase: "however,"

Phrase: "incubation"

Phrase: "with the AMPK activator 5-aminoimidazole-4-carboxamide-riboside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0597413:riboside [Carbohydrate]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "AMPK activity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C1150527:protein kinase activity [Molecular Function]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   875   C1537044:protein activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "twofold"

Phrase: "and"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "all of these changes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.10: Likewise, expression of a constitutively active AMPK in HUVEC prevented the increase in caspase-3 activity. 

Phrase: "Likewise,"

Phrase: "expression of a constitutively active AMPK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in HUVEC"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the increase in caspase-3 activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]
Processing 00000000.tx.11: The results indicate that alterations in fatty-acid metabolism, impaired Akt activation by insulin, and increased caspase-3 activity precede visible evidence of apoptosis in HUVEC incubated in a hyperglycemic medium. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that alterations in fatty-acid metabolism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "impaired Akt activation by insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "increased caspase-3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1150132:caspase-3 activity [Molecular Function]
   902   C0474395:increased activity [Finding]
   875   C1150130:caspase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "precede"

Phrase: "visible evidence of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in HUVEC"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in a hyperglycemic medium."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
Processing 00000000.tx.12: They also suggest that AMPK could play an important role in protecting the endothelial cell against the adverse effects of sustained hyperglycemia.  

Phrase: "They also"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that AMPK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in protecting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "the endothelial cell against the adverse effects of sustained hyperglycemia."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0225336:Endothelial cell [Cell]
   757   C0007634:THE CELL [Cell]
           Cell
   739   C0014257:Endothelial [Tissue]
   739   C1269647:Cell [Cell]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Vascular disease that affects both the micro- and macrovasculature is the principal cause of morbidity and mortality in patients with diabetes (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Vascular disease"
Meta Candidates (Total=17; Excluded=12; Pruned=0; Remaining=5)
  1000   C0042373:Vascular disease [Disease or Syndrome]
   950 E C0018939:Blood disease NOS [Disease or Syndrome]
   950 E C1533163:Blood disease [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0012634:Disease [Disease or Syndrome]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "that"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "both the micro-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085672:MICRO [Laboratory Procedure]
  1000   C1553035:Micro [Quantitative Concept]

Phrase: "and"

Phrase: "macrovasculature"

Phrase: "is"

Phrase: "the principal cause of morbidity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015127:cause [Functional Concept]
   760   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "mortality in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026565:Mortality [Quantitative Concept]
   790   C0026566:mortality [Quantitative Concept]

Phrase: "with diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: A wide variety of studies suggest that an early site at which these vascular complications develop is the endothelium. 

Phrase: "A wide variety of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "an early site at which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "these vascular complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]

Phrase: "develop"

Phrase: "is"

Phrase: "the endothelium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014257:Endothelium [Tissue]
Processing 00000000.tx.15: In particular, early abnormalities such as increases in renal and retinal blood flow, impaired vasodilation in response to physiological and pharmacological stimuli, and increased vascular permeability have been attributed to endothelial cell damage (1). 

Phrase: "In particular, early abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "such as increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "in renal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022646:Renal [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "retinal blood flow,"
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
   901   C0232338:Blood flow [Organism Function]
   859   C0035330:Retinal blood vessel [Body Part, Organ, or Organ Component]
   851 E C0549652:RETINAL VASCULAR [Pathologic Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0035298:Retinal [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C0806140:Flow [Natural Phenomenon or Process]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "impaired vasodilation in response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0042401:Vasodilation [Physiologic Function]
   770   C0595862:VASODILATION [Pathologic Function]
   770   C3537065:Vasodilation [Physiologic Function]

Phrase: "to physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pharmacological stimuli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "and"

Phrase: "increased vascular permeability"
Meta Candidates (Total=15; Excluded=9; Pruned=0; Remaining=6)
  1000   C2314904:Increased Vascular Permeability [Physiologic Function]
   981 E C0232374:Increased blood vessel permeability [Finding]
   901   C0162337:Vascular Permeability [Organ or Tissue Function]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0031164:Permeability [Natural Phenomenon or Process]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   755 E C0205326:Permeable [Functional Concept]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "attributed to endothelial cell damage"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0225336:Endothelial cell [Cell]
   806   C0599732:cell damage [Cell or Molecular Dysfunction]
   760   C0007634:Cell [Cell]
   760   C0010957:Damage [Injury or Poisoning]
   760   C0014257:Endothelial [Tissue]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1883709:Damage [Functional Concept]
   760   C1948049:Cell [Spatial Concept]
   726   C0449234:Attribute [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Morphological correlates of these functional abnormalities were not initially identified; 

Phrase: "Morphological correlates of these functional abnormalities"

Phrase: "were"

Phrase: "not initially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205265:Initially [Temporal Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ";"
Processing 00000000.tx.17: however, recent studies have shown an increase in apoptosis in various organs affected by diabetes, including the eye (2,3), heart (4,5), and vascular endothelium (5). 

Phrase: "however,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an increase in apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "in various organs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178784:organs [Body Part, Organ, or Organ Component]

Phrase: "affected by diabetes,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the eye"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0015392:Eye [Body Part, Organ, or Organ Component]
  1000   C1280202:Eye [Body Part, Organ, or Organ Component]
   944 E C0029144:optic [Occupation or Discipline]
   944 E C0042789:Ocular [Organism Function]
   944 E C1299003:Ocular [Spatial Concept]
   907 E C0014236:Ophthalmia [Disease or Syndrome]
   907 E C0700042:Oculus [Body Location or Region]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "heart"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "vascular endothelium"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014261:Endothelium, Vascular [Tissue]
   972 E C1706972:Blood Vessel Endothelium [Tissue]
   861   C0014257:Endothelium [Tissue]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.18: The Diabetes Control and Complications Trial (6) and the U.K. 

Phrase: "The Diabetes Control and Complications Trial"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   875   C0342257:Diabetes Complications [Pathologic Function]
   804   C0008976:Trial [Research Activity]
   804   C0009566:Complications [Pathologic Function]
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C0243148:control [Qualitative Concept]
   804   C1171258:complications [Pathologic Function]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   771 E C2362589:Complication [Idea or Concept]
   721 E C0231242:Complicated [Functional Concept]

Phrase: "(6"

Phrase: ")"

Phrase: "and"

Phrase: "the U.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.19: Prospective Diabetes Study (7,8) have linked hyperglycemia to the occurrence of microvascular disease in patients with diabetes. 

Phrase: "Prospective Diabetes Study"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0033522:prospective study [Research Activity]
   913   C1709709:Prospective Study [Research Activity]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "(7,"

Phrase: "8"

Phrase: ")"

Phrase: "have"

Phrase: "linked hyperglycemia to the occurrence of microvascular disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.20: Although less clear-cut, a relationship between hyperglycemia and macrovascular disease (9) has also been reported. 

Phrase: "Although"

Phrase: "less clear-cut,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0000925:Cut [Injury or Poisoning]
   827   C1883724:CUT [Phenomenon or Process]
   827   C2963144:Clear [Qualitative Concept]

Phrase: "a relationship between hyperglycemia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "macrovascular disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(9"

Phrase: ")"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.21: That hyperglycemia increases apoptosis in cultured endothelium was first demonstrated by Barmgartner-Parzer et al. 

Phrase: "That hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "apoptosis in cultured endothelium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "demonstrated by Barmgartner-Parzer et al."
Processing 00000000.tx.22: (10) in HUVECs and since then by many others (11,12,13). 

Phrase: "(10"

Phrase: ")"

Phrase: "in HUVECs"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "since then by many others"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1711239:Since [Temporal Concept]
   760   C1883708:Then [Temporal Concept]
   760   C1955473:Others [Finding]

Phrase: "(11,"

Phrase: "12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.23: It is well-established that apoptosis can be induced by internal signals, such as cytochrome C and apoptosis-inducing factors released from mitochondria, and that it is commonly associated with decreases in mitochondrial membrane potential and ATP production (14,15,16). 

Phrase: "It"

Phrase: "is"

Phrase: "well-established"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C0443211:Established [Qualitative Concept]
   861   C1272684:Established [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "induced by internal signals,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205102:Internal [Spatial Concept]
   770   C0205263:Induced [Functional Concept]
   770   C1553872:Internal [Intellectual Product]
   770   C1619620:Internal [Intellectual Product]
   737   C1710082:Signal [Phenomenon or Process]

Phrase: "such as cytochrome C"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "and"

Phrase: "apoptosis-inducing factors"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   966   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "released from mitochondria,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0026237:Mitochondria [Cell Component]
   790   C0391871:Released [Functional Concept]
   790   C1283071:Released [Functional Concept]
   756 E C0030685:Release [Health Care Activity]
   756 E C0439180:% release [Quantitative Concept]
   756 E C0680255:release [Health Care Activity]
   756 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "commonly"

Phrase: "associated with decreases"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0547047:decreases [Quantitative Concept]
   756 E C0392756:Decrease [Qualitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "ATP production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "(14,"

Phrase: "15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.24: In addition, such factors as caspases, ceramide, and oxidative stress have been implicated in its causation, whereas other factors, including shear stress, IGF-I, insulin, and Akt activation, have been shown to be antiapoptotic (17,18,19,20,21). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "such factors as caspases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "ceramide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "and"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in its causation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0085978:Causation [Idea or Concept]
   770   C1524003:Causation [Conceptual Entity]

Phrase: "whereas"

Phrase: "other factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "shear stress,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1171318:shear stress [Natural Phenomenon or Process]
   861   C0038435:Stress [Finding]
   861   C0175735:shear [Medical Device]
   861   C0205013:shear [Therapeutic or Preventive Procedure]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "IGF-I,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "Akt activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "antiapoptotic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986514:antiapoptotic [Chemical Viewed Functionally]

Phrase: "(17,"

Phrase: "18,"

Phrase: "19,"

Phrase: "20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.25: Despite this, the metabolic mechanism(s) by which hyperglycemia initiates apoptosis in endothelium is incompletely understood. 

Phrase: "Despite this,"

Phrase: "the metabolic mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "s) by which hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020456:Hyperglycaemia [Disease or Syndrome]
   770   C2603362:S' [Clinical Attribute]

Phrase: "initiates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "apoptosis in endothelium"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "incompletely"

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.26: This article addresses the notion that the apoptosis caused by sustained hyperglycemia in cultured HUVECs is associated with alterations in intracellular fatty-acid metabolism. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "addresses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the notion"

Phrase: "that"

Phrase: "the apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "caused by sustained hyperglycemia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020456:Hyperglycaemia [Disease or Syndrome]
   770   C0443318:Sustained [Functional Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "in cultured HUVECs"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   947   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   895   C0007600:cultured cells [Cell]
   895   C0007635:Cultured Cells [Cell]
   895   C3282338:Cells, Cultured [Cell]
   876   C0427861:Human cells [Laboratory or Test Result]
   827   C0041637:Umbilical vein [Embryonic Structure]
   827   C0221313:Umbilical vein [Embryonic Structure]
   827   C0225336:Endothelial Cells [Cell]
   827   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   799   C0007634:Cells [Cell]
   799   C0014257:Endothelial [Tissue]
   799   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   799   C0042449:Vein [Body Part, Organ, or Organ Component]
   799   C0086418:Human [Human]
   799   C1278960:Vein [Body Part, Organ, or Organ Component]
   799   C3282337:Cells [Cell]
   791   C1179027:Vein Endothelium [Tissue]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "associated with alterations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756   C1515926:Alteration [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in intracellular fatty-acid metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0596563:Fatty Acid Metabolism [Molecular Function]
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.27: Early studies showed that incubation with 5-aminoimidazole-4-carboxamide-riboside (AICAR), which activates AMPK by formation of ZMP, enhances fatty-acid oxidation in many cells (22) and inhibits apoptosis in thymocytes treated with glucocorticoids (23) and cultured fibroblasts deprived of growth factors (24). 

Phrase: "Early studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that incubation with 5-aminoimidazole-4-carboxamide-riboside (AICAR),"

Phrase: "which"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "AMPK by formation of ZMP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0597295:protein formation [Molecular Function]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "fatty-acid oxidation in many cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1158366:fatty acid oxidation [Molecular Function]
   790   C0015684:Fatty acid [Lipid]
   753   C0001128:Acid [Chemical]
   753   C0030011:Oxidation [Molecular Function]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis in thymocytes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   841   C2610925:thymocyte apoptosis [Cell Function]
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "treated with glucocorticoids"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0017710:Glucocorticoids [Hormone,Steroid]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "cultured fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "deprived of growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.28: The mechanism responsible for this antiapoptotic action was not examined. 

Phrase: "The mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for this antiapoptotic action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.29: For this reason, in the present study, the effects of AICAR on fatty-acid metabolism and on indexes of apoptosis, such as TdT-mediated dUTP nick-end labeling (TUNEL) staining and caspase-3 activity, were evaluated in HUVEC exposed to media enriched in glucose. 

Phrase: "For this reason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:Reason [Idea or Concept]

Phrase: "in the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the effects of AICAR"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on fatty-acid metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596563:Fatty Acid Metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0015684:Fatty acid [Lipid]

Phrase: "and on indexes of apoptosis,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0162638:Apoptosis [Cell Function]
   760   C0600653:Indexes [Intellectual Product]
   760   C0918012:indexes [Intellectual Product]
   760   C1515981:And [Idea or Concept]
   726 E C1552854:index [Idea or Concept]
   726 E C1637833:% index [Quantitative Concept]

Phrase: "such as TdT-mediated dUTP nick-end labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1167624:Labeling [Mental Process]
   799   C1947902:Labeling [Manufactured Object]
   799   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "(TUNEL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600528:TUNEL [Molecular Biology Research Technique]

Phrase: ")"

Phrase: "staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "caspase-3 activity,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "evaluated in HUVEC"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0225336:Endothelial Cells [Cell]
   783   C0427861:Human cells [Laboratory or Test Result]
   753   C0007634:Cells [Cell]
   753   C0014257:Endothelial [Tissue]
   753   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   753   C0086418:Human [Human]
   753   C0220825:Evaluated [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to media"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "enriched in glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0359583:enriched [Food]
Processing 00000000.tx.30: In addition, the effect of expressing a constitutively active AMPK on caspase-3 activity in these cells was examined. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the effect of expressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "a constitutively active AMPK on caspase-3 activity"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   795   C2261493:protein kinase A activity [Molecular Function]
   777   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   777   C1150527:protein kinase activity [Molecular Function]
   775   C2261472:A-kinase activity [Molecular Function]
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   759 E C2261495:protein phosphokinase activity [Molecular Function]
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   757   C1150423:kinase activity [Molecular Function]
   757   C1537044:protein activity [Molecular Function]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.31: A preliminary report describing parts of this work has appeared elsewhere (25).  

Phrase: "A preliminary report describing parts of this work"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1292711:Part of [Spatial Concept]
   744   C0449719:parts [Spatial Concept]
   744   C1709471:PARTS [Quantitative Concept]

Phrase: "has"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "elsewhere"

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.32: RESEARCH DESIGN AND METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  All chemicals were obtained from Sigma (St. Louis, MO), and radioactive materials were obtained from NEN (Boston, MA) unless otherwise stated. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0086912:methods research [Research Activity]
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "All chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "obtained from Sigma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "radioactive materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "were"

Phrase: "obtained from NEN"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA)"

Phrase: "unless"

Phrase: "otherwise"

Phrase: "stated."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]
Processing 00000000.tx.33: HUVECs and EBM-2 growth media with EGM-2 bullet kit were purchased from Clonetics (San Diego, CA). 

Phrase: "HUVECs"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "EBM-2 growth media with EGM-2 bullet kit"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   764   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   742   C0009458:Media [Intellectual Product]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0162867:Media [Tissue]
   742   C0220844:growth [Physiologic Function]
   742   C1254021:Media [Tissue]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2911660:Growth [Activity]
   708 E C0439536:Medium [Quantitative Concept]
   708 E C1705217:Medium [Substance]
   708 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "purchased from Clonetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.34: Cells in passage 56 were used. 

Phrase: "Cells in passage 56"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.35: Assessment of apoptosis by TUNEL staining. 

Phrase: "Assessment of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1261322:Assessment [Health Care Activity]
   790   C1516048:Assessment [Activity]

Phrase: "by TUNEL staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.36: Cells were grown to confluence in EBM-2 medium with EGM-2 bullet kit in 60-mm dishes or six-well plates. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown to confluence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205200:Confluent [Qualitative Concept]

Phrase: "in EBM-2 medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "with EGM-2 bullet kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "in 60-mm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0020498:DISH [Disease or Syndrome]

Phrase: "or"

Phrase: "six-well plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.37: The medium was then changed to Medium-199 (containing phenol red as pH indicator) supplemented with 10% fetal bovine serum (FBS; certified from Gibco), antibiotics, and additions as indicated in RESULTS. 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "changed to Medium-199"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0392747:Changed [Functional Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C0443172:Changed [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "(containing phenol red as pH indicator"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031430:Phenol Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   753   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   753   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   753   C0332575:Red [Finding]
   753   C1260956:Red [Qualitative Concept]

Phrase: ")"

Phrase: "supplemented with 10% fetal bovine serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(FBS"

Phrase: ";"

Phrase: "certified from Gibco"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0007836:Certified [Governmental or Regulatory Activity]

Phrase: ")"

Phrase: ","

Phrase: "antibiotics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003232:Antibiotics [Antibiotic]

Phrase: "and"

Phrase: "additions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C1883712:Addition [Functional Concept]
   916 E C1524062:Additional [Functional Concept]

Phrase: "as"

Phrase: "indicated in RESULTS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1444656:Indicated [Finding]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]
Processing 00000000.tx.38: After 72 h of incubation, during which the medium was changed daily, the cells were fixed with 2% paraformaldehyde in phosphate buffer. 

Phrase: "After 72 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of incubation,"

Phrase: "during which"

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "daily,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332173:Daily [Temporal Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed with 2% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in phosphate buffer."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.39: Apoptosis was assessed without knowledge of cell source by one of us (Y.I.) by TUNEL staining with diaminobenzidine using a kit obtained from Oncogene (Boston, MA). 

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "assessed without knowledge of cell source"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0007634:Cell [Cell]
   753   C0376554:Knowledge [Intellectual Product]
   753   C0449416:Source [Finding]
   753   C1269647:Cell [Cell]
   753   C1516048:Assessed [Activity]
   753   C1704653:Cell [Medical Device]
   753   C1705919:Source [Idea or Concept]
   753   C1948049:Cell [Spatial Concept]

Phrase: "by one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of us (Y.I.)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "by TUNEL staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "with diaminobenzidine"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812225:KIT [Medical Device]
  1000   C1150635:KIT [Molecular Function]
  1000   C1705212:Kit [Medical Device]
  1000   C1705213:KIT [Medical Device]
  1000   C3273202:Kit [Manufactured Object]

Phrase: "obtained from Oncogene"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0029016:Oncogene [Gene or Genome]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.40: The number of stained cells was assessed using the computer software program NIH image, not by human eyes, to avoid potential subjective errors. 

Phrase: "The number of stained cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the computer software program NIH image,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1704254:Image [Intellectual Product]
   804   C1704922:Image [Entity]
   804   C3542466:Image [Intellectual Product]

Phrase: "not by human eyes,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0015392:Eyes [Body Part, Organ, or Organ Component]
   770   C0086418:Human [Human]
   770   C1518422:Not [Functional Concept]
   737 E C1280202:Eye [Body Part, Organ, or Organ Component]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "potential subjective errors."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0743559:errors [Qualitative Concept]
   793 E C1608199:Error [Functional Concept]
Processing 00000000.tx.41: Nuclear fragmentation was also assessed at high magnification by light microscopy to confirm apoptosis. 

Phrase: "Nuclear fragmentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "was"

Phrase: "also"

Phrase: "assessed at high magnification"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C1516048:Assessed [Activity]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "by light microscopy to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0430389:Light microscopy [Laboratory Procedure]
   827   C0026018:Microscopy [Laboratory Procedure]
   755 E C0205288:Microscopic [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.42: In separate experiments, Annexin-V and propidium iodide double staining were performed to distinguish apoptosis from necrosis. 

Phrase: "In separate experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "Annexin-V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "propidium iodide double staining"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0205173:Double [Functional Concept]
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]
   812   C1705764:Double [Activity]
   812   C1705765:Double [Qualitative Concept]
   779 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish"

Phrase: "apoptosis from necrosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.43: Percentage apoptosis was calculated from the number of TUNEL-positive cells divided by the total number of cells counted. 

Phrase: "Percentage apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "calculated from the number of TUNEL-positive cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   770   C0439178:% positive cells [Quantitative Concept]
           % Positive
   750   C0007584:Cell Number [Laboratory Procedure]
   744   C0007634:Cells [Cell]
   744   C0237753:*Number [Quantitative Concept]
   744   C0444686:Calculated [Functional Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C0600528:TUNEL [Molecular Biology Research Technique]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]
   744   C1446409:Positive [Qualitative Concept]
   744   C1514241:Positive [Finding]
   744   C2825490:Positive [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "divided by the total number of cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   774   C1441375:Cells.total [Cell]
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0007634:Cells [Cell]
   748   C0237753:*Number [Quantitative Concept]
   748   C0332849:Divided [Functional Concept]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "counted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.44: Three to five images obtained in a systematically random manner were analyzed in each dish, representing 1,0001,500 cells per dish. 

Phrase: "Three to five images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1704254:Image [Intellectual Product]
   779   C1704922:Image [Entity]
   779   C3542466:Image [Intellectual Product]

Phrase: "obtained in a systematically random manner"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0034656:RANDOM [Research Activity]
   753   C0439605:Random [Qualitative Concept]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "were"

Phrase: "analyzed in each dish,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020498:DISH [Disease or Syndrome]
   770   C0936012:Analyzed [Research Activity]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "0001,"

Phrase: "500 cells per dish."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   898   C2347576:Cell per Dish [Quantitative Concept]
           Cells/dish
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.45: Because of some variation among the dishes, even in the same treatment group, eight dishes or three wells of a six-well culture plate were evaluated for each treatment group. 

Phrase: "Because of some variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "among the dishes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020498:DISH [Disease or Syndrome]

Phrase: "even in the same treatment group,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0441833:Group [Idea or Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705169:Treatment [Conceptual Entity]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "eight dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020498:DISH [Disease or Syndrome]

Phrase: "or"

Phrase: "three wells of a six-well culture plate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0205170:Well [Qualitative Concept]
   711   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "evaluated for each treatment group."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0220825:Evaluated [Functional Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705169:Treatment [Conceptual Entity]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.46: Assessment of apoptosis by caspase-3 activity. 

Phrase: "Assessment of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1261322:Assessment [Health Care Activity]
   790   C1516048:Assessment [Activity]

Phrase: "by caspase-3 activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.47: Although morphological assessment revealed clear changes in the number of TUNEL-positive cells, we measured caspase-3 activity to confirm that apoptosis was occurring. 

Phrase: "Although"

Phrase: "morphological assessment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1261322:Assessment [Health Care Activity]
   861   C1516048:Assessment [Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "clear changes in the number of TUNEL-positive cells,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0392747:changes [Functional Concept]
   742   C0443172:changes [Quantitative Concept]
   708 E C1705241:Change [Quantitative Concept]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "caspase-3 activity to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1150132:caspase-3 activity [Molecular Function]
   875   C1150130:caspase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "occurring."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.48: Cells were grown in six-well plates to reach confluence and were exposed to Medium-199 supplemented with 10% FBS with 5 or 30 mmol/l glucose  1 mmol/l AICAR for 24 h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in six-well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C0205452:Six [Quantitative Concept]
   770   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "confluence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205200:Confluent [Qualitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "exposed to Medium-199"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10% FBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "with 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "30 mmol/l glucose  1 mmol/l AICAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0597413:riboside [Carbohydrate]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.49: In the experiments using adenovirus, cells were infected for 24 h, and medium was changed to Medium-199 supplemented with 10% FBS with 5 or 30 mmol/l glucose, and the cells were harvested 24 h later. 

Phrase: "In the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "adenovirus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001483:Adenovirus, NOS [Virus]
  1000   C0001486:Adenovirus [Disease or Syndrome]
  1000   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "infected for 24 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0439663:Infected [Functional Concept]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed to Medium-199"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0392747:Changed [Functional Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C0443172:Changed [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "supplemented with 10% FBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "with 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "30 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "24 h later."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.50: Caspase-3 activity was assessed in cell extracts with an EnzChek Caspase-3 Assay Kit #2 (Molecular Probes, Eugene, OR) by measuring the fluorescence signal of the cleaved product by the enzyme. 

Phrase: "Caspase-3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "in cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "extracts with an EnzChek Caspase-3 Assay Kit #2"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0243073:assay [Qualitative Concept]
   742   C0812225:KIT [Medical Device]
   742   C1150635:KIT [Molecular Function]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1705212:Kit [Medical Device]
   742   C1705213:KIT [Medical Device]
   742   C2828366:Extract [Substance]
   742   C3273202:Kit [Manufactured Object]

Phrase: "(Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Eugene,"

Phrase: "OR) by measuring"

Phrase: "the fluorescence signal of the cleaved product"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "by the enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.51: Values for activity were normalized for cell protein. 

Phrase: "Values for activity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   805   C3645543:Active value [Qualitative Concept]
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "normalized for cell protein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:Cell [Cell]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1882115:Normalized [Research Activity]
   770   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.52: Constitutively active AMP-kinase adenovirus. 

Phrase: "Constitutively active AMP-kinase adenovirus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0001483:Adenovirus, NOS [Virus]
   804   C0001486:Adenovirus [Disease or Syndrome]
   804   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.53: Constitutively active AMP-kinase adenovirus was constructed from truncated rat 1 subunit with aspartate substituted for Threonine 172 (1312T172D) (26,27). 

Phrase: "Constitutively active AMP-kinase adenovirus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0001483:Adenovirus, NOS [Virus]
   804   C0001486:Adenovirus [Disease or Syndrome]
   804   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "constructed from truncated rat 1 subunit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1514732:Rat-1 [Cell]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C1711351:Subunit [Quantitative Concept]
   719   C2827421:Construct [Classification]

Phrase: "with aspartate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "substituted for Threonine 172"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(1312T172D"

Phrase: ")"

Phrase: "(26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.54: The virus also coexpressed GFP by a second promotor, so GFP expression could be used to assess the efficiency of infection. 

Phrase: "The virus also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042776:Virus [Virus]
   861   C0319157:virus [Virus]

Phrase: "coexpressed"

Phrase: "GFP by a second promotor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "so"

Phrase: "GFP expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the efficiency of infection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013682:Efficiency [Quantitative Concept]
Processing 00000000.tx.55: Preliminary studies revealed that within 24 h of infection, nearly all (>90%) the endothelial cells expressed GFP and that AMP-independent AMP-kinase activity was three- to fivefold higher than in control cells. 

Phrase: "Preliminary studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439611:Preliminary [Temporal Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that within 24 h of infection,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0009450:Infection, NOS [Disease or Syndrome]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "nearly"

Phrase: "all (>90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: "the endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressed"

Phrase: "GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "that AMP-independent AMP-kinase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "three-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "to fivefold higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "than"

Phrase: "in control cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.56: This AMP-kinase activity was similar to that found in HUVEC treated with 1 mmol/l AICAR for 12 h. 

Phrase: "This AMP-kinase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "found in HUVEC"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C0225336:Endothelial Cells [Cell]
   783   C0427861:Human cells [Laboratory or Test Result]
   753   C0007634:Cells [Cell]
   753   C0014257:Endothelial [Tissue]
   753   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   753   C0086418:Human [Human]
   753   C0150312:Found [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C0243095:Find [Finding]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "treated with 1 mmol/l AICAR"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   764   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   764   C1532563:mmol/L [Quantitative Concept]
   762   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   742   C0439190:MMOLE [Quantitative Concept]
   742   C0597413:riboside [Carbohydrate]
   742   C1522326:Treated [Functional Concept]
   708 E C1292734:TREAT [Functional Concept]

Phrase: "for 12 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.57: Metabolic studies. 

Phrase: "Metabolic studies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0280606:Metabolic Studies [Diagnostic Procedure]
  1000   C0412467:Metabolic studies [Diagnostic Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.58: As described by others (10) and as shown here (Fig. 1), incubation in media containing 30 mmol/l glucose does not increase apoptosis in HUVEC after 24 h, but it does by 72 h. 

Phrase: "As"

Phrase: "described by others"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   790   C1955473:Others [Finding]

Phrase: "(10"

Phrase: ")"

Phrase: "and"

Phrase: "as"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "incubation in media"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "30 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "apoptosis in HUVEC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3156636:endothelial cell apoptosis [Cell Function]
   753   C0162638:Apoptosis [Cell Function]

Phrase: "after 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "but"

Phrase: "it"

Phrase: "does by 72 h."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1272751:Does [Finding]
   770   C2828361:Does [Activity]
Processing 00000000.tx.59: For this reason, metabolic and signaling changes antedating the increase in TUNEL staining were evaluated in cells incubated for 24 h in Medium-199 supplemented with 10% FBS and 50 mol/l carnitine. 

Phrase: "For this reason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:Reason [Idea or Concept]

Phrase: "metabolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311400:Metabolic [Functional Concept]
  1000   C1524026:Metabolic [Cell Function]
  1000   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "signaling changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "antedating"

Phrase: "the increase in TUNEL staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "were"

Phrase: "evaluated in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0220825:Evaluated [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "incubated for 24 h in Medium-199"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0009458:Medium [Intellectual Product]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439536:Medium [Quantitative Concept]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1705217:Medium [Substance]
   748   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10% FBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "50 mol/l carnitine."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0347982:mol/L [Quantitative Concept]
   812   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.60: Glucose oxidation was assessed by determining 14CO2 released into the incubation medium during a 2-h incubation with [U-14C]glucose. 

Phrase: "Glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "assessed by determining 14CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1516048:Assessed [Activity]

Phrase: "released into the incubation medium"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0009458:Medium [Intellectual Product]
   760   C0391871:Released [Functional Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1283071:Released [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "during a 2-h incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0011744:2 H [Element, Ion, or Isotope]

Phrase: "with"

Phrase: "[U-14C"

Phrase: "]glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.61: In separate experiments, free fatty oxidation was determined from 3H2O production as previously described using [3H]palmitic acid as a substrate (28). 

Phrase: "In separate experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "free fatty oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "determined from 3H2O production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]palmitic acid as a substrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0030234:Palmitic Acid [Biologically Active Substance,Lipid]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.62: For this measurement, the cells were first preincubated for 24 h with radioactive palmitate, because unless intracellular lipid pools are prelabeled, the rate of fatty-acid oxidation was greatly underestimated (29). 

Phrase: "For this measurement,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "preincubated for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "with radioactive palmitate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030233:palmitate [Lipid]
   861   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "because"

Phrase: "unless"

Phrase: "intracellular lipid pools"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0337051:pools [Geographic Area]
   793 E C1509144:pool [Clinical Attribute]
   793 E C2349200:Pool [Functional Concept]

Phrase: "are"

Phrase: "prelabeled"

Phrase: ","

Phrase: "the rate of fatty-acid oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "greatly"

Phrase: "underestimated"

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.63: Incorporation of label into cell diacylglycerol was assessed after its separation by thin-layer chromatography. 

Phrase: "Incorporation of label"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0243126:incorporation [Functional Concept]

Phrase: "into cell diacylglycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043791:Diacylglycerol [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "was"

Phrase: "assessed after its separation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0036679:Separation [Pathologic Function]
   770   C0237868:Separation [Social Behavior]
   770   C1516048:Assessed [Activity]
   770   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "by thin-layer chromatography."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C0205168:Thin [Qualitative Concept]
   827   C0934502:Layer [Body Part, Organ, or Organ Component]
   827   C1522408:Layer [Qualitative Concept]
   827   C1561599:Layer [Intellectual Product]
   755 E C0039870:Thinness [Finding]
   727 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.64: Cell protein was measured by the bicinchoninic acid (BSA) assay. 

Phrase: "Cell protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured by the bicinchoninic acid"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0053554:bicinchoninic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "(BSA) assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.65: View larger version (62K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(62K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.66: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.67: Effects of AICAR on hyperglycemia-induced apoptosis. 

Phrase: "Effects of AICAR"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on hyperglycemia-induced apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.68: A: HUVECs were incubated for 72 h in Medium-199 + 10% FBS  1 mmol/l AICAR at the indicated glucose concentration. 

Phrase: "A"

Phrase: ":"

Phrase: "HUVECs"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 72 h in Medium-199 + 10% FBS  1 mmol/l AICAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0597413:riboside [Carbohydrate]

Phrase: "at the indicated glucose concentration."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.69: Typical TUNEL staining (dark brown) with methylene blue counterstaining. 

Phrase: "Typical TUNEL staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "(dark brown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: ")"

Phrase: "with methylene blue counterstaining."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0025746:Methylene blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.70: TUNEL-positive cells showed a typical apoptotic configuration with shrinkage and nuclear fragmentation. 

Phrase: "TUNEL-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0439178:% positive cells [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a typical apoptotic configuration with shrinkage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449830:Configuration [Spatial Concept]
   753   C2827597:Configuration [Conceptual Entity]

Phrase: "and"

Phrase: "nuclear fragmentation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]
Processing 00000000.tx.71: Representative pictures are shown. 

Phrase: "Representative pictures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441469:pictures [Manufactured Object]
   827 E C0441468:picture [Manufactured Object]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.72: (See RESEARCH DESIGN AND METHODS for details). 

Phrase: "("

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS for details"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   756 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.73: B: The percentage of TUNEL-positive cells was determined in three wells of six-well plates (24 h) or in eight of 60-mm dishes. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "The percentage of TUNEL-positive cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "determined in three wells of six-well"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205449:Three [Quantitative Concept]
   748   C0205452:Six [Quantitative Concept]
   714   C0205170:Well [Qualitative Concept]
   714   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "(24 h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "or in eight of 60-mm dishes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205454:Eight [Quantitative Concept]
   714   C0020498:DISH [Disease or Syndrome]
Processing 00000000.tx.74: Data are means  SD; 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SD"

Phrase: ";"
Processing 00000000.tx.75: *P < 0.05, vs. 

Phrase: "*P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.76: 5 mmol/l glucose; 

Phrase: "5 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.77: P < 0.05, vs. 

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.78: 30 mmol/l glucose alone. 

Phrase: "30 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.79: C: Caspase-3 activity in HUVEC incubated for 24 h in 5 or 30 mmol/l glucose in the presence or absence of AICAR (left; results are means  SE; n = 5); 

Phrase: "C"

Phrase: ":"

Phrase: "Caspase-3 activity in HUVEC"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C1150132:caspase-3 activity [Molecular Function]
   767   C0020115:Human Activity [Activity]
   767   C1150130:caspase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "30 mmol/l glucose in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "absence of AICAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "; results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "means  SE"

Phrase: "; n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.80: *P < 0.05, vs. 

Phrase: "*P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.81: 5 mmol/l glucose; 

Phrase: "5 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.82: P < 0.05, vs. 

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.83: 30 mmol/l glucose alone and HUVEC infected with a GFP-tagged control adenovirus or the adenovirus linked to constitutively active AMPK (right; results are means  SE; n = 6); 

Phrase: "30 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "HUVEC"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "infected with a GFP-tagged control adenovirus"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   748   C0001483:Adenovirus, NOS [Virus]
   748   C0001486:Adenovirus [Disease or Syndrome]
   748   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   748   C0243148:control [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1550141:Control [Substance]
   748   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1708632:Tagged [Qualitative Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "the adenovirus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001483:Adenovirus, NOS [Virus]
  1000   C0001486:Adenovirus [Disease or Syndrome]
  1000   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "to constitutively active AMPK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "; results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "means  SE"

Phrase: "; n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.84: *P < 0.05, 5 mmol/l glucose with GFP alone; 

Phrase: "*P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "5 mmol/l glucose with GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: ";"
Processing 00000000.tx.85: P < 0.05, vs. 

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.86: 30 mmol/l glucose with GFP alone. 

Phrase: "30 mmol/l glucose with GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.87: Approximately 95% of the cells showed positively for GFP. 

Phrase: "Approximately 95% of the cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0332232:Approximately [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "positively for GFP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.88: AMPK activity was three- to fourfold higher in the cells infected with the constitutively active AMPK virus.  

Phrase: "AMPK activity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C1150527:protein kinase activity [Molecular Function]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   875   C1537044:protein activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "three-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "to fourfold higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "in the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the constitutively active AMPK virus."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0042736:Virus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0042776:Virus [Virus]
   742   C0205177:Active [Functional Concept]
   742   C0319157:virus [Virus]
   742   C0439663:Infected [Functional Concept]
   742   C1879547:Activated [Activity]
   708 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.89: Mitochondrial membrane potential and ATP measurement. 

Phrase: "Mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "ATP measurement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.90: Mitochondrial membrane potential was estimated by incubating the cells for 15 min with a depolarizing buffer containing HEPES pH 7.4, 20 mmol/l NaCl, 110 mmol/l KCl, 2 mmol/l MgCl2, 1.5 mmol/l CaCl2, 1 mmol/l NaPO4, and 0.01 Ci/ml 3H-tetraphenylphosphonium (TPP; from Amersham, Piscataway, NJ). 

Phrase: "Mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "estimated by incubating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750572:Estimated [Quantitative Concept]
   790   C1439852:incubating [Laboratory Procedure]

Phrase: "the cells for 15 min"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:THE CELL [Cell]
           Cells
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "with a depolarizing buffer containing HEPES pH 7.4,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   829   C2678549:PH-4 [Gene or Genome]
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0332256:Containing [Functional Concept]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C2700400:Containing [Activity]

Phrase: "20 mmol/l NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "110 mmol/l KCl,"

Phrase: "2 mmol/l MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1.5 mmol/l CaCl2,"

Phrase: "1 mmol/l NaPO4,"

Phrase: "and"

Phrase: "0.01 Ci/ml 3H-tetraphenylphosphonium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0076326:tetraphenylphosphonium [Indicator, Reagent, or Diagnostic Aid,Organophosphorus Compound]

Phrase: "(TPP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039848:TPP [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: ";"

Phrase: "from Amersham,"

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.91: The final concentration of TPP was 5 nmol/l, well below the concentration reported to inhibit mitochondrial respiration (30). 

Phrase: "The final concentration of TPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "5 nmol/l,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C2348935:.5 L [Quantitative Concept]
   901   C0439282:nmol/L [Quantitative Concept]

Phrase: "well below the concentration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086045:Concentration [Mental Process]
   770   C0205170:Well [Qualitative Concept]
   770   C1446561:Concentration [Quantitative Concept]
   770   C3146287:Well [Manufactured Object]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "mitochondrial respiration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035203:Respiration [Physiologic Function]
   861   C0282636:respiration [Cell Function]
   861   C1160636:respiration [Biologic Function]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.92: After incubation, the cells were washed with ice-cold phosphate-buffered saline three times and solubilized with NaOH, and the radioactivity and protein content were measured. 

Phrase: "After incubation,"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with ice-cold phosphate-buffered saline three times"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   764   C0456963:Ice cold [Qualitative Concept]
   762   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0009264:Cold [Natural Phenomenon or Process]
   742   C0009443:Cold [Disease or Syndrome]
   742   C0020746:Ice [Inorganic Chemical]
   742   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   742   C0031701:phosphate [Organophosphorus Compound]
   742   C0036082:Saline [Substance]
   742   C0040223:times [Temporal Concept]
   742   C0205449:Three [Quantitative Concept]
   742   C0234192:Cold [Physiologic Function]
   742   C1548982:Washed [Idea or Concept]
   742   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   742   C1632851:Times [Quantitative Concept]
   708 E C0441648:Wash [Activity]
   708 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "solubilized with NaOH,"

Phrase: "and"

Phrase: "the radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "protein content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "were"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.93: Cellular ATP levels were determined with a luminometric assay kit from Sigma as described previously (28). 

Phrase: "Cellular ATP levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined with a luminometric assay kit"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0812225:KIT [Medical Device]
   753   C1150635:KIT [Molecular Function]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1705212:Kit [Medical Device]
   753   C1705213:KIT [Medical Device]
   753   C3273202:Kit [Manufactured Object]

Phrase: "from Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.94: Akt Western blot. 

Phrase: "Akt Western blot."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   901   C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]
Processing 00000000.tx.95: Confluent cells in 100-mm dishes were incubated in Medium-199 supplemented with 1% FBS for 24 h and then were incubated with 150 U/ml insulin for 20 min. 

Phrase: "Confluent cells in 100-mm dishes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C1441340:100 cells [Cell]
   767   C2347576:Cells/dish [Quantitative Concept]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "in Medium-199"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0009458:Medium [Intellectual Product]
   827   C0150312:In [Quantitative Concept]
   827   C0332285:In [Spatial Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 1% FBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "were"

Phrase: "incubated with 150 U/ml insulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0439340:U/ml [Quantitative Concept]
   790   C1880521:U/mL [Quantitative Concept]
   790   C2945590:U/mL [Quantitative Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0439526:/mL [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "for 20 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.96: Cells were harvested with a lysis buffer containing 20 mmol/l Tris-HCl (pH 8.0), 100 mmol/l NaCl, 25 mmol/l b-glycerophosphate, 1 mmol/l EDTA, 1 mmol/l EGTA, 1 mmol/l NaVO4, 1% NP-40, 1 mmol/l DTT, 1 mmol/l phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, and 10 g/ml pepstatin-A. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested with a lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:Lysis [Pathologic Function]
   760   C1536403:lysis [Cell Function]
   726   C1512335:Harvest [Health Care Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20 mmol/l Tris-HCl (pH 8.0"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C1532563:mmol/L [Quantitative Concept]
   793   C0020283:[pH] [Quantitative Concept]
   793   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   793   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   793   C0439190:MMOLE [Quantitative Concept]
   793   C0450407:ph+ [Finding]
   793   C0450408:ph++ [Finding]
   793   C0450409:ph+++ [Finding]
   793   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "100 mmol/l NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "25 mmol/l b-glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "1 mmol/l EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mmol/l EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1 mmol/l NaVO4,"

Phrase: "1% NP-40,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0044508:1-NP [Hazardous or Poisonous Substance,Organic Chemical]
   901   C0068941:NP-40 [Organic Chemical,Pharmacologic Substance]
   827   C0439509:/40 [Temporal Concept]
   827   C1706141:NP [Gene or Genome]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "1 mmol/l DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "1 mmol/l phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "10 g/ml pepstatin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A."
Processing 00000000.tx.97: Proteins were separated by SDS-PAGE and transferred onto a polyvinylidene fluoride membrane. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "transferred onto a polyvinylidene fluoride membrane."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0071710:polyvinylidene fluoride [Organic Chemical]
   753   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   753   C0025255:Membrane [Tissue]
   753   C0348011:transferred [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]
Processing 00000000.tx.98: Phosphorylation of Akt was assessed with antiphospho-S473 Akt antibody. 

Phrase: "Phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "assessed with antiphospho-S473 Akt antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0812228:AKT [Gene or Genome]
   753   C1516048:Assessed [Activity]
Processing 00000000.tx.99: After stripping, total Akt with an antibody obtained from Cell Signaling Technologies (Beverly, MA) was assessed. 

Phrase: "After stripping,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185047:Stripping [Therapeutic or Preventive Procedure]

Phrase: "total Akt with an antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0812228:AKT [Gene or Genome]

Phrase: "obtained from Cell Signaling Technologies"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   813   C1371607:Increased Cell Signaling [Cell Function]
   806   C0037083:Cell Signaling [Cell Function]
           Signaling
   760   C0007634:Cell [Cell]
   760   C0039421:technologies [Occupation or Discipline]
   760   C1269647:Cell [Cell]
   760   C1301820:Obtained [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3537152:signaling [Biologic Function]
   726 E C1706701:Obtain [Activity]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "(Beverly,"

Phrase: "MA)"

Phrase: "was"

Phrase: "assessed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]
Processing 00000000.tx.100: Ceramide and serine incorporation into ceramide. 

Phrase: "Ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "and"

Phrase: "serine incorporation into ceramide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]
Processing 00000000.tx.101: Ceramide levels were assessed in lipid extracts of cells grown in 100-mm dish by converting ceramide to ceramide-1-phosphate using diacylglycerol (DAG)-kinase and 32P-ATP followed by thin-layer chromatography (31). 

Phrase: "Ceramide levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "assessed in lipid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023779:Lipid [Lipid]
   790   C1516048:Assessed [Activity]

Phrase: "extracts of cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   841   C0007592:Cell Extracts [Cell Component]
   790   C0007634:Cells [Cell]
   790   C2828366:Extract [Substance]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "grown in 100-mm dish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020498:DISH [Disease or Syndrome]

Phrase: "by converting ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "to ceramide-1-phosphate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0246257:ceramide 1-phosphate [Lipid]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   734   C1695071:CERAMIDE 1 [Lipid,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "diacylglycerol (DAG)-kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0113519:Diacylglycerol Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0043791:Diacylglycerol [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "and"

Phrase: "32P-ATP"

Phrase: "followed by thin-layer chromatography"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0205168:Thin [Qualitative Concept]
   760   C0934502:Layer [Body Part, Organ, or Organ Component]
   760   C1522408:Layer [Qualitative Concept]
   760   C1561599:Layer [Intellectual Product]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.102: Serine incorporation into ceramide was assessed in cells incubated with 3H-serine (final specific activity, 1,000 dpm/pmol) for 16 h. 

Phrase: "Serine incorporation into ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "assessed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1516048:Assessed [Activity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "incubated with 3H-serine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1442460:3H [Temporal Concept]

Phrase: "(final specific activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0205369:Specific [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1552740:specific [Intellectual Product]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "1,000 dpm/pmol) for 16 h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439192:pmol [Quantitative Concept]
Processing 00000000.tx.103: Malonyl-CoA. 

Phrase: "Malonyl-CoA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024645:Malonyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.104: Malonyl-CoA was measured in a neutralized 0.6-N perchloric acid cell extract by the method described by Foester and Lynen (32). 

Phrase: "Malonyl-CoA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024645:Malonyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "measured in a neutralized 0.6-N perchloric acid cell extract"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   756   C0030981:Perchloric acid [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   738   C0001128:Acid [Chemical]
   738   C0007634:Cell [Cell]
   738   C0202406:Acid [Laboratory Procedure]
   738   C0444706:Measured [Qualitative Concept]
   738   C1269647:Cell [Cell]
   738   C1704653:Cell [Medical Device]
   738   C1948049:Cell [Spatial Concept]
   738   C2828366:Extract [Substance]
   738   C3541902:MEASURED [Diagnostic Procedure]
   704 E C0079809:Measure [Quantitative Concept]
   704 E C0242485:Measure [Functional Concept]

Phrase: "by the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "described by Foester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Lynen"

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.105: Fatty acid synthase was purified from Bakers yeast (33). 

Phrase: "Fatty acid synthase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0015683:Fatty-acid synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1367441:FATTY ACID SYNTHASE [Gene or Genome]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "purified from Bakers yeast"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0036025:Bakers Yeast [Fungus]
           yeast
   770   C0043392:Yeast [Food]
   770   C0043393:Yeast [Fungus]
   770   C0238749:bakers [Professional or Occupational Group]
   770   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   770   C1998793:Purified [Functional Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.106: AMP-kinase activity was assayed in ammonium sulfate precipitates of the cell homogenate by measuring the phosphorylation of SAMS peptide (28). 

Phrase: "AMP-kinase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "assayed in ammonium sulfate"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0002620:Ammonium Sulfate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   770   C0002611:Ammonium [Inorganic Chemical]
   770   C0038720:Sulfate [Inorganic Chemical]
   770   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   770   C3536965:SULFATE [Element, Ion, or Isotope]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "precipitates of the cell homogenate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1882443:PRECIPITATE [Phenomenon or Process]
   760   C1948049:Cell [Spatial Concept]

Phrase: "by measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the phosphorylation of SAMS peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.107: Statistics. 

Phrase: "Statistics."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.108: Statistical analysis was done by the general linear models procedure in SAS program on a Macintosh computer.  

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "done by the general linear models procedure"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0023732:Linear Models [Quantitative Concept]
   748   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   748   C0205132:Linear [Spatial Concept]
   748   C0205246:General [Spatial Concept]
   748   C1272695:Done [Qualitative Concept]
   748   C1553889:General [Idea or Concept]
   748   C1948041:Procedure [Therapeutic or Preventive Procedure]
   748   C2700391:Procedure [Activity]
   748   C2746065:Done [Temporal Concept]
   748   C3161035:Models [Intellectual Product]
   748   C3274430:PROCEDURE [Health Care Activity]
   748   C3538935:Procedure [Idea or Concept]
   748   C3539779:Procedure [Intellectual Product]

Phrase: "in SAS program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "on a Macintosh computer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009622:Computer [Manufactured Object]
Processing 00000000.tx.109: RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Hyperglycemia-induced apoptosis is inhibited by AICAR and by expression of constitutively active AMP-kinase. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hyperglycemia-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "inhibited by AICAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C0597413:riboside [Carbohydrate]

Phrase: "and by expression of constitutively active AMP-kinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205177:Active [Functional Concept]
   744   C1515981:And [Idea or Concept]
Processing 00000000.tx.110: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.111: 1, the percentage of TUNEL-positive cells was similar (34%) in HUVEC incubated for 24 h in the EBM-2 media containing 5 or 30 mmol/l glucose. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "the percentage of TUNEL-positive cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "(34%"

Phrase: ")"

Phrase: "in HUVEC"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the EBM-2 media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "30 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.112: In addition, no differences in cell number, morphology, or protein were observed at this time (data not shown). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "no differences in cell number,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007584:Cell Number [Laboratory Procedure]
   812   C0237753:*Number [Quantitative Concept]
   812   C0449788:Number [Quantitative Concept]

Phrase: "morphology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "or"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "observed at this time"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0040223:Time [Temporal Concept]
   770   C1441672:Observed [Functional Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: By 72 h, however, a significantly greater percentage of cells (18 vs. 13%; P < 0.05) incubated at the higher glucose concentration were apoptotic. 

Phrase: "By 72 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "however,"

Phrase: "a significantly greater percentage of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "(18"

Phrase: "vs. 13%"

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "incubated at the higher glucose concentration"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0427743:Glucose concentration [Laboratory Procedure]
   790   C1287281:Glucose concentration [Laboratory or Test Result]
   773   C0860803:high glucose [Finding]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0086045:Concentration [Mental Process]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1446561:Concentration [Quantitative Concept]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "were"

Phrase: "apoptotic."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1516044:Apoptotic [Qualitative Concept]
   928 E C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.114: As also shown in Fig. 

Phrase: "As"

Phrase: "also"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.115: 1, AICAR had no affect on apoptotic rate in cells incubated in 30 mmol/l glucose after 24 h, but it completely prevented the increase in apoptosis caused by hyperglycemia at 72 h. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "AICAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597413:riboside [Carbohydrate]
   708   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "had"

Phrase: "no"

Phrase: "affect on apoptotic rate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001721:Affect [Mental Process]
   770   C0871208:Rate [Activity]
   770   C1516044:Apoptotic [Qualitative Concept]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in 30 mmol/l glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "after 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "but"

Phrase: "it completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the increase in apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "caused by hyperglycemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020456:Hyperglycaemia [Disease or Syndrome]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "at 72 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.116: No increase in apoptosis was observed at 72 h in an osmotic control in which cells were incubated with 5 mmol/l glucose and 25 mmol/l mannitol, in agreement with the findings of others (11) (data not shown). 

Phrase: "No increase in apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed at 72 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "in an osmotic control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "in which cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with 5 mmol/l glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "25 mmol/l mannitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024730:Mannitol [Carbohydrate,Pharmacologic Substance]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with the findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "of others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "(11"

Phrase: ")"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.117: Similar results were obtained with Annexin-V staining. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with Annexin-V staining."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1332095:ANNEXIN V [Gene or Genome]
   760   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1301820:Obtained [Functional Concept]
   760   C1704680:Staining [Finding]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.118: Of note, <5% of the Annexin-Vpositive cells demonstrated nuclear staining with propidium iodide, indicating that they were predominantly apoptotic and not necrotic (data not shown). 

Phrase: "Of note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "<5% of the Annexin-Vpositive cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439084:>5 [Quantitative Concept]
   753   C0728893:+5 [Quantitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "demonstrated"

Phrase: "nuclear staining with propidium iodide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "indicating"

Phrase: "that"

Phrase: "they"

Phrase: "were"

Phrase: "predominantly apoptotic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1516044:Apoptotic [Qualitative Concept]
   789 E C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "not necrotic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027540:Necrotic [Organ or Tissue Function]
   789 E C1334928:Necrosis [Finding]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.119: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.120: 1, an increase in caspase-3 activity, which is thought to be an early signal of apoptosis, was evident in cells incubated with 30 mmol/l glucose for 24 h (1,225  42 arbitrary units vs. 1,002  61 for 5 mmol/l glucose; P < 0.01; n = 5), and it was also completely prevented by addition of AICAR (833  14 arbitrary units; P < 0.01 vs. 30 mmol/l glucose). 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "an increase in caspase-3 activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an early signal of apoptosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "evident in cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0332120:Evidence [Functional Concept]

Phrase: "incubated with 30 mmol/l glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 24 h (1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0700308:h 1 [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "225  42 arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0439183:Arbitrary unit [Quantitative Concept]
   812   C0439148:Units [Quantitative Concept]
   812   C1264693:*Arbitrary [Quantitative Concept]
   812   C1519795:Units [Quantitative Concept]
   779 E C1704753:Unit [Manufactured Object]
   779 E C1880519:Unit [Quantitative Concept]

Phrase: "vs. 1,002  61 for 5 mmol/l glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1532563:mmol/L [Quantitative Concept]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0439190:MMOLE [Quantitative Concept]
   742   C1704629:VS [Idea or Concept]
   742   C1704752:VS [Intellectual Product]

Phrase: "; P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "was"

Phrase: "also completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "prevented by addition of AICAR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   744   C0597413:riboside [Carbohydrate]
   744   C1883712:Addition [Functional Concept]
   711   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(833  14 arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0439183:Arbitrary unit [Quantitative Concept]
   812   C0439148:Units [Quantitative Concept]
   812   C1264693:*Arbitrary [Quantitative Concept]
   812   C1519795:Units [Quantitative Concept]
   779 E C1704753:Unit [Manufactured Object]
   779 E C1880519:Unit [Quantitative Concept]

Phrase: "; P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. 30 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.121: A similar decrease in caspase-3 activity was observed when AMPK activity was increased by infecting HUVEC with constitutively active AMPK using an adenoviral vector (Fig. 1). 

Phrase: "A similar decrease in caspase-3 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "AMPK activity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C1150527:protein kinase activity [Molecular Function]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   875   C1537044:protein activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "increased by infecting HUVEC"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0225336:Endothelial Cells [Cell]
   774   C0427861:Human cells [Laboratory or Test Result]
   748   C0007634:Cells [Cell]
   748   C0014257:Endothelial [Tissue]
   748   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   748   C0086418:Human [Human]
   748   C0205217:Increased [Quantitative Concept]
   748   C0439663:infecting [Functional Concept]
   748   C0442805:Increased [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "with constitutively active AMPK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an adenoviral vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1510800:Adenoviral Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.122: Changes in mitochondrial function and cellular ATP are prevented by AICAR. 

Phrase: "Changes in mitochondrial function"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "cellular ATP"

Phrase: "are"

Phrase: "prevented by AICAR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   753   C0597413:riboside [Carbohydrate]
   719   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.123: As a first step in delineating events that precede the increase in TUNEL staining, mitochondrial membrane potential and ATP content were evaluated in HUVEC incubated for 24 h at the two glucose concentrations. 

Phrase: "As a first step in delineating events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0441471:Events [Event]
   804   C3541888:Events [Classification]

Phrase: "that"

Phrase: "precede"

Phrase: "the increase in TUNEL staining,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "ATP content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "were"

Phrase: "evaluated in HUVEC"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0225336:Endothelial Cells [Cell]
   783   C0427861:Human cells [Laboratory or Test Result]
   753   C0007634:Cells [Cell]
   753   C0014257:Endothelial [Tissue]
   753   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   753   C0086418:Human [Human]
   753   C0220825:Evaluated [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at the two glucose concentrations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C0427743:Glucose concentration [Laboratory Procedure]
   884   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.124: Although we did not estimate absolute membrane potential, accumulated TPP+ was reduced significantly after incubation for 24 h at 30 mmol/l glucose, suggesting that it was diminished. 

Phrase: "Although"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "absolute membrane potential,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0025251:Membrane Potential [Cell Function]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "accumulated TPP+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039848:TPP [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "significantly"

Phrase: "after"

Phrase: "incubation for 24 h"

Phrase: "at 30 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "was"

Phrase: "diminished."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]
Processing 00000000.tx.125: This effect was totally prevented by AICAR (Fig. 2). 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "totally"

Phrase: "prevented by AICAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   753   C0597413:riboside [Carbohydrate]
   719   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.126: Very similar changes were observed in cellular ATP levels, which were diminished after incubation with 30 mmol/l glucose but were, if anything, higher than control values when AICAR was added to the medium. 

Phrase: "Very similar changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "observed in cellular ATP levels,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "were"

Phrase: "diminished after incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205216:Diminished [Quantitative Concept]

Phrase: "with 30 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "but"

Phrase: "were"

Phrase: ","

Phrase: "if"

Phrase: "anything,"

Phrase: "higher than control values"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "when"

Phrase: "AICAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597413:riboside [Carbohydrate]
   708   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to the medium."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.127: View larger version (34K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.128: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.129: Mitochondrial membrane potential (A) and cellular ATP (B). 

Phrase: "Mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "cellular ATP"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.130: Mitochondrial membrane potential was estimated after 24 h of exposure to glucose  1 mmol/l AICAR by incubating cells with 3H-TPP in a depolarizing buffer (see text). 

Phrase: "Mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "estimated after 24 h of exposure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C0750572:Estimated [Quantitative Concept]

Phrase: "to glucose  1 mmol/l AICAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0597413:riboside [Carbohydrate]

Phrase: "by incubating cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with 3H-TPP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039848:TPP [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "in a depolarizing buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.131: Data are means  SE (n = 6). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE (n = 6"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C1704970:Means [Conceptual Entity]
   779 E C0444504:Mean [Quantitative Concept]
   779 E C2347634:Mean [Quantitative Concept]
   779 E C2348143:Mean [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.132: *P < 0.05, vs. 

Phrase: "*P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.133: 5 mmol/l glucose; 

Phrase: "5 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.134: P < 0.05, vs. 

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.135: 30 mmol/l glucose.  

Phrase: "30 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.136: Sustained hyperglycemia alters intracellular fatty-acid and glucose metabolism and Akt activation but does not alter ceramide content or de novo synthesis. 

Phrase: "Sustained hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "intracellular fatty-acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "Akt activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "but"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "ceramide content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "or"

Phrase: "de novo synthesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   734   C1515568:de novo [Idea or Concept]
Processing 00000000.tx.137: We showed previously that incubation of HUVEC for 2 h in media containing 30 mmol/l vs. 

Phrase: "We"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "that incubation of HUVEC"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "30 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: "vs."
Processing 00000000.tx.138: 5 mmol/l glucose causes no changes in AMPK activity, malonyl-CoA concentration, fatty-acid oxidation, or lactate release. 

Phrase: "5 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "no changes in AMPK activity,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   762   C0442739:No change [Finding]
   762   C1548568:No change [Intellectual Product]
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "malonyl-CoA concentration,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0024645:Malonyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "fatty-acid oxidation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "lactate release."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.139: In contrast, incubation at this glucose concentration for 24 h resulted in increases in the concentration of malonyl-CoA, diminished fatty-acid oxidation, and an increased incorporation of both radioactive glucose and radioactive palmitate into diacylglycerol (Fig. 3). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "incubation at this glucose concentration"

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "resulted in increases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442805:increases [Functional Concept]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "in the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of malonyl-CoA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024645:Malonyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "fatty-acid oxidation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "an increased incorporation of both radioactive glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243126:incorporation [Functional Concept]

Phrase: "and"

Phrase: "radioactive palmitate into diacylglycerol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030233:palmitate [Lipid]
   770   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.140: In addition, it impaired Akt phosphorylation in the presence of insulin (Fig. 4). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "Akt phosphorylation in the presence of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.141: Like the decrease in mitochondrial membrane potential and increases in caspase-3 activity caused by hyperglycemia, these changes were completely prevented by incubation with AICAR; 

Phrase: "Like the decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "in mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "increases in caspase-3 activity"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C1150132:caspase-3 activity [Molecular Function]
   806   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   797   C1150130:caspase activity [Molecular Function]
   760   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0442805:Increase [Functional Concept]
   760   C1561536:*Activity [Idea or Concept]
   756   C0474395:increased activity [Finding]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "caused by hyperglycemia,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020456:Hyperglycaemia [Disease or Syndrome]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "these changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "prevented by incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "with AICAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597413:riboside [Carbohydrate]
   708   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.142: indeed, the concentration of malonyl-CoA was even lower than that in cells incubated with 5 mmol/l glucose. 

Phrase: "indeed,"

Phrase: "the concentration of malonyl-CoA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "even lower than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated with 5 mmol/l glucose."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.143: AMPK activity tended to be higher after 24 h of incubation with 30 mmol/l glucose; 

Phrase: "AMPK activity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C1150527:protein kinase activity [Molecular Function]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   875   C1537044:protein activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "higher after 24 h of incubation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "with 30 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.144: however, whether it was inappropriately low, in light of the decrease in ATP content (and presumably an increased AMP/ATP ratio), was not ascertained. 

Phrase: "however,"

Phrase: "whether"

Phrase: "it"

Phrase: "was"

Phrase: "inappropriately low,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "in light of the decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "in ATP content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "("

Phrase: "and"

Phrase: "presumably"

Phrase: "an increased AMP/ATP ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "ascertained."
Processing 00000000.tx.145: View larger version (59K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(59K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.146: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.147: Fatty-acid metabolism (A and B), AMP-kinase (C), and malonyl-CoA (D). 

Phrase: "Fatty-acid metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596563:Fatty Acid Metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0015684:Fatty acid [Lipid]

Phrase: "(A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "AMP-kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "malonyl-CoA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024645:Malonyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.148: All parameters were measured in HUVECs incubated with Medium-199 + 10% FBS  1 mmol/l AICAR for 24 h. 

Phrase: "All parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]

Phrase: "were"

Phrase: "measured in HUVECs"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   897   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   778   C0041637:Umbilical vein [Embryonic Structure]
   778   C0221313:Umbilical vein [Embryonic Structure]
   778   C0225336:Endothelial Cells [Cell]
   778   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   774   C0427861:Human cells [Laboratory or Test Result]
   748   C0007634:Cells [Cell]
   748   C0014257:Endothelial [Tissue]
   748   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   748   C0042449:Vein [Body Part, Organ, or Organ Component]
   748   C0086418:Human [Human]
   748   C0444706:Measured [Qualitative Concept]
   748   C1278960:Vein [Body Part, Organ, or Organ Component]
   748   C3282337:Cells [Cell]
   748   C3541902:MEASURED [Diagnostic Procedure]
   743   C1179027:Vein Endothelium [Tissue]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "with Medium-199 + 10% FBS  1 mmol/l AICAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0597413:riboside [Carbohydrate]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.149: Fatty-acid oxidation was measured over 2 h after 24 h of prelabeling with 3H-palmitate. 

Phrase: "Fatty-acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "measured over 2 h"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0444706:Measured [Qualitative Concept]
   770   C0564385:/h [Quantitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "after 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of prelabeling"

Phrase: "with 3H-palmitate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030233:palmitate [Lipid]
   861   C3503116:palmitate [Biomedical or Dental Material,Lipid]
Processing 00000000.tx.150: Data are means  SE (n = 46). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE (n = 46"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C1704970:Means [Conceptual Entity]
   779 E C0444504:Mean [Quantitative Concept]
   779 E C2347634:Mean [Quantitative Concept]
   779 E C2348143:Mean [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.151: *P < 0.05, vs. 

Phrase: "*P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.152: 5 mmol/l glucose; 

Phrase: "5 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.153: P < 0.05, vs. 

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.154: 30 mmol/l glucose.  

Phrase: "30 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.155: View larger version (36K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.156: 4. 

Phrase: "4."
Processing 00000000.tx.157: Akt. 

Phrase: "Akt."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]
Processing 00000000.tx.158: A: Representative blots showing the effects of 24-h incubation with 5 or 30 mmol/l glucose  1 mmol/l AICAR on Akt phosphorylation by insulin and abundance. 

Phrase: "A"

Phrase: ":"

Phrase: "Representative blots"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the effects of 24-h incubation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "with 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "30 mmol/l glucose  1 mmol/l AICAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0597413:riboside [Carbohydrate]

Phrase: "on Akt phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "abundance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346714:Abundance [Qualitative Concept]
Processing 00000000.tx.159: B: Akt phosphorylation/unit abundance. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Akt phosphorylation/unit abundance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2346714:Abundance [Qualitative Concept]
Processing 00000000.tx.160: Results are means  SE (n = 4). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "means  SE (n = 4"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C1704970:Means [Conceptual Entity]
   779 E C0444504:Mean [Quantitative Concept]
   779 E C2347634:Mean [Quantitative Concept]
   779 E C2348143:Mean [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.161: *P < 0.05, vs. 

Phrase: "*P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.162: 5 mmol/l glucose; 

Phrase: "5 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.163: P < 0.05, vs. 

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.164: 30 mmol/l glucose.  

Phrase: "30 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.165: To assess whether alterations in ceramide contributed to these events and particularly the decrease in membrane potential, we attempted to measure ceramide content. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "whether"

Phrase: "alterations in ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1515926:Alteration [Idea or Concept]

Phrase: "contributed to these events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441471:Events [Event]
   770   C3541888:Events [Classification]
   737   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "particularly"

Phrase: "the decrease in membrane potential,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "we"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "ceramide content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.166: Ceramide was not detectable in HUVEC incubated with either 5 or 30 mmol/l glucose. 

Phrase: "Ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "was"

Phrase: "not detectable in HUVEC"

Phrase: "incubated with either 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "30 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.167: In contrast, HUVEC incubated in a medium containing 5 mmol/l glucose and 0.1 mmol/l palmitate for 24 h showed a ceramide band on autoradiography but no increase in TUNEL staining (data not shown). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "HUVEC"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in a medium containing 5 mmol/l glucose"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C1532563:mmol/L [Quantitative Concept]
   742   C0009458:Medium [Intellectual Product]
   742   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0332256:Containing [Functional Concept]
   742   C0439190:MMOLE [Quantitative Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1705217:Medium [Substance]
   742   C2700400:Containing [Activity]
   742   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "0.1 mmol/l palmitate for 24 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0030233:palmitate [Lipid]
   744   C3503116:palmitate [Biomedical or Dental Material,Lipid]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a ceramide band on autoradiography"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0230715:A band [Cell Component]
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: "but"

Phrase: "no increase in TUNEL staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.168: Consistent with these findings, we found no increase in serine incorporation into ceramide (presumably a measure of de novo synthesis) in cells incubated for 24 h in 30 vs. 

Phrase: "Consistent with these findings,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no increase in serine incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "into ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007745:Ceramide [Biologically Active Substance,Lipid]

Phrase: "(presumably"

Phrase: "a measure of de novo synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079809:Measure [Quantitative Concept]
   753   C0242485:Measure [Functional Concept]

Phrase: ")"

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 30"

Phrase: "vs."
Processing 00000000.tx.169: 5 mmol/l glucose. 

Phrase: "5 mmol/l glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]
Processing 00000000.tx.170: Observed values were 8.4  0.5, 10.8  0.4, and 9.0  1.2 pmol/mg (n = 4) in cells incubated in 5 and 30 mmol/l glucose and 30 mmol/l glucose plus AICAR, respectively. 

Phrase: "Observed values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "8.4  0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444499:0/5 [Quantitative Concept]

Phrase: "10.8  0.4,"

Phrase: "and"

Phrase: "9.0  1.2 pmol/mg (n = 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0439292:pmol/mg [Quantitative Concept]
   793   C0439192:pmol [Quantitative Concept]
   793   C0439269:mg% [Quantitative Concept]
   793   C1960952:mg % [Quantitative Concept]
   793   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated in 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "30 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "30 mmol/l glucose plus AICAR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0597413:riboside [Carbohydrate]

Phrase: "respectively."
Processing 00000000.tx.171: Glucose metabolism. 

Phrase: "Glucose metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.172: Hyperglycemia caused a small but significant increase in lactate release by HUVEC but did not alter either pyruvate release or glucose oxidation (Fig. 5). 

Phrase: "Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "but"

Phrase: "significant increase in lactate release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "by HUVEC"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "either pyruvate release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.173: Incubation with AICAR diminished both lactate and pyruvate release, as it has been reported to do in endothelial cells incubated for 2 h with 5 mmol/l glucose (28). 

Phrase: "Incubation with AICAR"

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "both lactate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022924:lactate [Organic Chemical]
  1000   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "pyruvate release,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to do in endothelial cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883351:To [Qualitative Concept]

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with 5 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.174: In addition, and in contrast to the latter situation, it caused glucose oxidation to diminish by 60% (Fig. 5). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "and in contrast to the latter situation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1515981:And [Idea or Concept]
   748   C1979874:Contrast [Qualitative Concept]

Phrase: "it"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "glucose oxidation to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030011:Oxidation [Molecular Function]

Phrase: "diminish by 60%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205216:diminish [Quantitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.175: View larger version (53K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(53K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.176: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.177: Glucose metabolism: lactate production (A), pyruvate production (B), glucose oxidation (C), and glucose incorporation into DAG (D). 

Phrase: "Glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "lactate production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "pyruvate production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "glucose incorporation into DAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.178: All parameters were measured in HUVECs incubated with Medium-199 + 10% FBS  1 mmol/l AICAR for 24 h. 

Phrase: "All parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]

Phrase: "were"

Phrase: "measured in HUVECs"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   897   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   778   C0041637:Umbilical vein [Embryonic Structure]
   778   C0221313:Umbilical vein [Embryonic Structure]
   778   C0225336:Endothelial Cells [Cell]
   778   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   774   C0427861:Human cells [Laboratory or Test Result]
   748   C0007634:Cells [Cell]
   748   C0014257:Endothelial [Tissue]
   748   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   748   C0042449:Vein [Body Part, Organ, or Organ Component]
   748   C0086418:Human [Human]
   748   C0444706:Measured [Qualitative Concept]
   748   C1278960:Vein [Body Part, Organ, or Organ Component]
   748   C3282337:Cells [Cell]
   748   C3541902:MEASURED [Diagnostic Procedure]
   743   C1179027:Vein Endothelium [Tissue]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "with Medium-199 + 10% FBS  1 mmol/l AICAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0597413:riboside [Carbohydrate]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.179: Glycolysis (lactate and pyruvate release) and glucose oxidation were measured over 2 h in media containing [U-14C]glucose. 

Phrase: "Glycolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017952:Glycolysis [Molecular Function]

Phrase: "(lactate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022924:lactate [Organic Chemical]
  1000   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "pyruvate release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "were"

Phrase: "measured over 2 h"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0444706:Measured [Qualitative Concept]
   770   C0564385:/h [Quantitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "[U-14C"

Phrase: "]glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.180: Data are means  SE (n = 6). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means  SE (n = 6"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C1704970:Means [Conceptual Entity]
   779 E C0444504:Mean [Quantitative Concept]
   779 E C2347634:Mean [Quantitative Concept]
   779 E C2348143:Mean [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.181: *P < 0.05, vs. 

Phrase: "*P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.182: 5 mmol/l glucose; 

Phrase: "5 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.183: P < 0.05, vs. 

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.184: 30 mmol/l glucose.   

Phrase: "30 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.185: DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The principal findings of this study are fourfold. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The principal findings of this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C0683954:study findings [Finding]
   753   C2607943:findings [Functional Concept]
   753   C2926606:Findings [Clinical Attribute]
   753   C3539655:Findings [Intellectual Product]
   719 E C0037088:Finding [Sign or Symptom]
   719 E C0243095:Finding [Finding]
   719 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "fourfold."
Processing 00000000.tx.186: 1) Hyperglycemia-induced apoptosis in HUVEC, judged by TUNEL staining, is preceded by inhibition of fatty-acid oxidation, increases in fatty-acid esterification and the concentration of malonyl-CoA, and decreases in mitochondrial membrane potential and cellular ATP content. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Hyperglycemia-induced apoptosis in HUVEC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   776   C3156636:endothelial cell apoptosis [Cell Function]
   744   C0162638:Apoptosis [Cell Function]

Phrase: "judged by TUNEL staining,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0487602:Staining [Laboratory Procedure]
   770   C0600528:TUNEL [Molecular Biology Research Technique]
   770   C1704680:Staining [Finding]
   737   C0221191:Judge [Professional or Occupational Group]

Phrase: "is"

Phrase: "preceded by inhibition of fatty-acid oxidation,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   897   C2250059:inhibition of fatty acid oxidation [Cell Function]
   814   C1158366:fatty acid oxidation [Molecular Function]
   778   C0015684:Fatty acid [Lipid]
   748   C0001128:Acid [Chemical]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0030011:Oxidation [Molecular Function]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0332152:preceded [Temporal Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "increases in fatty-acid esterification"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0015684:Fatty acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0014895:Esterification [Natural Phenomenon or Process]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0442805:Increase [Functional Concept]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "the concentration of malonyl-CoA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "decreases in mitochondrial membrane potential"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   806   C0025251:Membrane Potential [Cell Function]
   806   C0596952:Mitochondrial membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   760   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "cellular ATP content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.187: 2) These metabolic alterations are associated with an increase in caspase-3 activity and an impaired ability of insulin at a physiological concentration to activate (phosphorylate) Akt. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "These metabolic alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "are"

Phrase: "associated with an increase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0442805:Increase [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in caspase-3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "an impaired ability of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "at a physiological concentration to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "("

Phrase: "phosphorylate"

Phrase: ")"

Phrase: "Akt."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]
Processing 00000000.tx.188: 3) Incubation with the cell-permeable AMPK activator AICAR prevents all of these changes. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "Incubation"

Phrase: "with the cell-permeable AMPK activator AICAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0597413:riboside [Carbohydrate]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "all of these changes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.189: 4) Overexpression of a constitutively active AMPK prevents the activation of caspase-3 by sustained hyperglycemia, suggesting that the antiapoptotic effect of AICAR is AMPK-mediated. 

Phrase: "4"

Phrase: ")"

Phrase: "Overexpression of a constitutively active AMPK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the activation of caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159825:Caspase Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "by sustained hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the antiapoptotic effect of AICAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "AMPK-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1879547:Activated [Activity]
   793 E C1515877:Activate [Functional Concept]

Phrase: "mediated."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.190: The finding that hyperglycemia of several days duration increases apoptosis in cultured HUVEC, as judged by cellular morphology and TUNEL staining, confirms the results of earlier investigations (10,11,12). 

Phrase: "The finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that hyperglycemia of several days duration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "apoptosis in cultured HUVEC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C3156636:endothelial cell apoptosis [Cell Function]
   748   C0162638:Apoptosis [Cell Function]

Phrase: "as"

Phrase: "judged by cellular morphology"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0243091:cellular morphology [Qualitative Concept]
   833   C1521816:Cellular Morphology [Clinical Attribute]
   833   C2700385:Cellular Morphology [Biomedical Occupation or Discipline]
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C0332437:Morphology [Qualitative Concept]
   770   C0543482:morphology [Spatial Concept]
   770   C0700329:Morphology, NOS [Finding]
   770   C0700619:Morphology [Biomedical Occupation or Discipline]
   737   C0221191:Judge [Professional or Occupational Group]

Phrase: "and"

Phrase: "TUNEL staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the results of earlier investigations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "(10,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.191: Recent studies have attributed this effect of hyperglycemia to increases in oxidative stress and intracellular Ca2+ that, in turn, lead to sequential increases in JNK/SAPK and caspase-3 activity (12). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "attributed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0449234:Attribute [Idea or Concept]
   966   C1704772:Attribute [Conceptual Entity]
   966   C1882133:Attribute [Qualitative Concept]

Phrase: "this effect of hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "to increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "in oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "intracellular Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "that,"

Phrase: "in turn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "lead to sequential increases"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0442805:increases [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1548958:Sequential [Idea or Concept]
   770   C1705294:Sequential [Qualitative Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in JNK/SAPK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0872265:SAPK [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1150586:SAPK [Molecular Function]
   861   C1334482:SAPK [Gene or Genome]

Phrase: "and"

Phrase: "caspase-3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.192: The results of the present study suggest involvement of two other events that have been implicated in causing apoptosis in other settings (14,16). 

Phrase: "The results of the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:results study [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "involvement of two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involvement [Functional Concept]

Phrase: "other events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "implicated in causing apoptosis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0162638:Apoptosis [Cell Function]
   770   C0678227:Causing [Functional Concept]
   737 E C0015127:cause [Functional Concept]
   737 E C1524003:Cause [Conceptual Entity]

Phrase: "in other settings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0542559:setting [Functional Concept]
   966   C1318139:{Setting} [Quantitative Concept]

Phrase: "(14,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.193: One of these is mitochondrial dysfunction, as evidenced by the loss of mitochondrial membrane potential () and a decrease in cellular ATP content, and the other is an impaired ability of insulin to stimulate the phosphorylation (and presumably the activation) of Akt. 

Phrase: "One of these"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "mitochondrial dysfunction,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "as"

Phrase: "evidenced by the loss of mitochondrial membrane potential"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   770   C0025251:Membrane Potential [Cell Function]
   770   C0596952:Mitochondrial membrane [Cell Component]
   750   C0332120:Evidence of [Functional Concept]
           Evidence
   744   C0025255:Membrane [Tissue]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C0596901:Membrane [Cell Component]
   744   C1517945:Loss [Quantitative Concept]
   744   C1706182:Membrane [Manufactured Object]
   744   C3245505:Potential [Qualitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "a decrease in cellular ATP content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "the other"

Phrase: "is"

Phrase: "an impaired ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "stimulate"

Phrase: "the phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "("

Phrase: "and"

Phrase: "presumably"

Phrase: "the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: ")"

Phrase: "of Akt."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]
Processing 00000000.tx.194: As recently reviewed (20), Akt plays a pivotal role in preventing apoptosis in a variety of settings. 

Phrase: "As"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a pivotal role in preventing apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883525:Variety [Conceptual Entity]
  1000   C2346866:Variety [Conceptual Entity]

Phrase: "of settings."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0542559:setting [Functional Concept]
   966   C1318139:{Setting} [Quantitative Concept]
Processing 00000000.tx.195: In particular, its activation is crucial for the ability of such factors as shear stress, insulin, and IGF-I and other growth factors (e.g., VEGF) to inhibit apoptosis in cultured endothelium (21,34). 

Phrase: "In particular,"

Phrase: "its activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "crucial for the ability of such factors"

Phrase: "as shear stress,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1171318:shear stress [Natural Phenomenon or Process]
   861   C0038435:Stress [Finding]
   861   C0175735:shear [Medical Device]
   861   C0205013:shear [Therapeutic or Preventive Procedure]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "other growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "VEGF) to"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis in cultured endothelium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "(21,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.196: Increases in DAG mass attributable to de novo synthesis and increased protein kinase C (PKC) activity have been described in endothelial cells incubated for 3 days in a hyperglycemic medium by Inoguchi et al. 

Phrase: "Increases in DAG mass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:increases [Functional Concept]

Phrase: "attributable to de novo synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596130:Attributable [Mental Process]

Phrase: "and"

Phrase: "increased protein kinase C (PKC) activity"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   937   C1150572:protein kinase C activity [Molecular Function]
   897   C0474395:increased activity [Finding]
   888   C1150527:protein kinase activity [Molecular Function]
   888   C3642159:Protein C Activity [Laboratory Procedure]
   875   C1537044:protein activity [Molecular Function]
   870 E C2261495:protein phosphokinase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   722   C1168113:increased protein c [Finding]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "have"

Phrase: "been"

Phrase: "described in endothelial cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0225336:Endothelial Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0014257:Endothelial [Tissue]
   770   C1552738:described [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "incubated for 3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439228:days [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "in a hyperglycemic medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "by Inoguchi et al."
Processing 00000000.tx.197: (35). 

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.198: The results of the present study both implicate malonyl-CoA in causing the changes and suggest that in HUVEC they can occur earlier than 3 days. 

Phrase: "The results of the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:results study [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "both"

Phrase: "implicate"

Phrase: "malonyl-CoA in causing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0024645:Malonyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that in HUVEC"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0225336:Endothelial Cells [Cell]
   783   C0427861:Human cells [Laboratory or Test Result]
   753   C0007634:Cells [Cell]
   753   C0014257:Endothelial [Tissue]
   753   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   753   C0086418:Human [Human]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "they"

Phrase: "can"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "earlier than 3 days."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1279919:Early [Temporal Concept]
Processing 00000000.tx.199: The relevance of the changes in lipid metabolism to the development of apoptosis remains to be determined. 

Phrase: "The relevance of the changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevance [Qualitative Concept]

Phrase: "in lipid metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598783:Lipid Metabolism [Molecular Function]
  1000   C1517898:Lipid Metabolism [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "to the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.200: Consistent with a potential causal role are the following: 1) the alterations in lipid metabolism antedated morphological evidence of apoptosis; 

Phrase: "Consistent with a potential causal role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "are"

Phrase: "the following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "the alterations in lipid metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0548934:Lipid Metabolism Alteration [Physiologic Function]
   726   C1515926:Alteration [Idea or Concept]

Phrase: "antedated"

Phrase: "morphological evidence of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: ";"
Processing 00000000.tx.201: 2) like the apoptosis, they were prevented by AICAR; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "like the apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "they"

Phrase: "were"

Phrase: "prevented by AICAR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   753   C0597413:riboside [Carbohydrate]
   719   C0309872:PREVENT [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.202: 3) by virtue of secondary effects on PKC activity, they offer a ready explanation for the impaired ability of insulin to activate Akt (36,37,38); 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "by virtue of secondary effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "on PKC activity,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C1150572:protein kinase C activity [Molecular Function]
   923   C1150527:protein kinase activity [Molecular Function]
   923   C3642159:Protein C Activity [Laboratory Procedure]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   902   C1537044:protein activity [Molecular Function]
   875   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "they"

Phrase: "offer"

Phrase: "a ready explanation for the impaired ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0681841:Explanation [Intellectual Product]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "(36,"

Phrase: "37,"

Phrase: "38"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.203: and 4) suppression of fatty-acid oxidation caused by inhibitors of carnitine palmitoyl transferase-1 produces apoptosis in other cells (39). 

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "suppression of fatty-acid oxidation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "caused by inhibitors of carnitine palmitoyl transferase-1"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   833   C0007262:Carnitine palmitoyltransferase 1 [Amino Acid, Peptide, or Protein,Enzyme]
           Carnitine Palmitoyltransferase
   833   C0085966:Carnitine Palmitoyltransferase I [Amino Acid, Peptide, or Protein,Enzyme]
   833   C2258044:carnitine palmitoyltransferase I [Molecular Function]
   770   C0729572:Palmitoyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   750   C1418824:INHIBITOR 1 [Gene or Genome]
   750   C1532411:Transferase inhibitor [Pharmacologic Substance]
   750   C1658753:transferase inhibitor [Molecular Function]
   744   C0007258:Carnitine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0087163:Carnitine [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   C0243077:inhibitors [Chemical Viewed Functionally]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]
   711 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "produces"

Phrase: "apoptosis in other cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.204: More definitive proof of a causal role will require the demonstration that the changes in lipid metabolism produced by hyperglycemia precede early apoptosis events (e.g., increased oxidative stress and caspase activity) and that their inhibition is required for the prevention by AMPK activation. 

Phrase: "More definitive proof of a causal role"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0556981:% proof [Quantitative Concept]

Phrase: "will"

Phrase: "require"

Phrase: "the demonstration"

Phrase: "that"

Phrase: "the changes in lipid metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025320:The change [Physiologic Function]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "produced by hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "precede"

Phrase: "early apoptosis events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150130:caspase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "that"

Phrase: "their inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "is"

Phrase: "required for the prevention"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1514873:Required [Functional Concept]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]

Phrase: "by AMPK activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1819041:protein kinase activation [Cell Function]
   875   C0599177:protein activation [Genetic Function]
   812   C1879547:Activation [Activity]
Processing 00000000.tx.205: AICAR has previously been shown to inhibit apoptosis in fibroblasts deprived of growth factors (24) and thymocytes exposed to glucocorticoids (23) and in cardiomyocytes (40) and astrocytes (41) exposed to fatty acids. 

Phrase: "AICAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597413:riboside [Carbohydrate]
   708   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis in fibroblasts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   841   C3159226:fibroblast apoptosis [Cell Function]
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "deprived of growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "(24"

Phrase: ")"

Phrase: "and"

Phrase: "thymocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0814999:Thymocytes [Cell]

Phrase: "exposed to glucocorticoids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "and in cardiomyocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0225828:Cardiomyocytes [Cell]
   790   C1515981:And [Idea or Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "(41"

Phrase: ")"

Phrase: "exposed to fatty acids."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0015684:Fatty Acids [Lipid]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0001128:Acids [Chemical]
   737 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.206: The multiplicity of situations in which it acts suggests that AICAR affects a common initial or terminal event in the apoptotic pathway (e.g., oxidative stress generation, Akt activation, Ca2+ regulation, or possibly the generation of inhibitory factors such as IGF). 

Phrase: "The multiplicity of situations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449822:Multiplicity [Quantitative Concept]

Phrase: "in which"

Phrase: "it"

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that AICAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597413:riboside [Carbohydrate]
   708   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "a common initial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205265:Initial [Temporal Concept]
   861   C1279901:Initial [Qualitative Concept]
   861   C1555582:Initial [Idea or Concept]
   861   C1705685:INITIAL [Functional Concept]

Phrase: "or"

Phrase: "terminal event in the apoptotic pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441471:Event [Event]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "oxidative stress generation,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0079411:Generation [Temporal Concept]
   827   C3146294:Generation [Activity]
   734   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   734 E C1414672:Genesis [Gene or Genome]
   734 E C2984892:Genesis [Gene or Genome]

Phrase: "Akt activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "Ca2+ regulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "or"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "the generation of inhibitory factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "such as IGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: ")."
Processing 00000000.tx.207: The results of the present study suggest that whatever the event(s) upon which it acts, the antiapoptotic action of AICAR is related to its ability to activate AMPK. 

Phrase: "The results of the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:results study [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "whatever the event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441471:Event [Event]

Phrase: "("

Phrase: "s) upon which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2603362:S' [Clinical Attribute]

Phrase: "it acts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "the antiapoptotic action of AICAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441472:Action [Functional Concept]
   744   C3266814:Action [Activity]

Phrase: "is"

Phrase: "related to its ability to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0085732:Ability [Organism Attribute]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "AMPK."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.208: The most compelling evidence for this is the observation that overexpression of a constitutively active AMPK causes a similar inhibition of caspase as does AICAR. 

Phrase: "The most compelling evidence for this"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that overexpression of a constitutively active AMPK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a similar inhibition of caspase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "as"

Phrase: "does"

Phrase: "AICAR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597413:riboside [Carbohydrate]
   708   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.209: Also, AMPK has been shown to phosphorylate (and activate) endothelial nitric oxide synthase (eNOS) on the same threonine residue as Akt (42). 

Phrase: "Also,"

Phrase: "AMPK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "phosphorylate"

Phrase: "("

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: ")"

Phrase: "endothelial nitric oxide synthase (eNOS) on the same threonine residue"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   818   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   790   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   764   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   762   C0076546:Threonine synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0014257:Endothelial [Tissue]
   742   C0030015:oxide [Inorganic Chemical]
   742   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "as Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.210: This would lead to the generation of NO, which, as already noted, is thought to mediate the antiapoptotic action on endothelium of such factors as shear stress and insulin (34,43). 

Phrase: "This"

Phrase: "would"

Phrase: "lead to the generation of NO,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0079411:Generation [Temporal Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3146294:Generation [Activity]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "which,"

Phrase: "as"

Phrase: "already"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the antiapoptotic action on endothelium of such factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441472:Action [Functional Concept]
   744   C3266814:Action [Activity]

Phrase: "as shear stress"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1171318:shear stress [Natural Phenomenon or Process]
   861   C0038435:Stress [Finding]
   861   C0175735:shear [Medical Device]
   861   C0205013:shear [Therapeutic or Preventive Procedure]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(34,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.211: However, independent of AMPK activation, AICAR causes the generation of adenosine and the intracellular accumulation of AICAR metabolites (29), such as ZMP and ZTP, all of which could affect cell function. 

Phrase: "However,"

Phrase: "independent of AMPK activation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1819041:protein kinase activation [Cell Function]
   875   C0599177:protein activation [Genetic Function]
   812   C1879547:Activation [Activity]

Phrase: "AICAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597413:riboside [Carbohydrate]
   708   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the generation of adenosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "the intracellular accumulation of AICAR metabolites"

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "such as ZMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0051028:ZMP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "ZTP,"

Phrase: "all of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "could"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cell function."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0007613:Cell Function [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705273:Function [Intellectual Product]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.212: For instance, the inhibition of glycolysis by AICAR in some cells, in- cluding endothelial cells (29), has been attributed to the accumulation of ZMP (44). 

Phrase: "For instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "the inhibition of glycolysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   909   C1512232:inhibition of glycolysis [Physiologic Function]
           Glycolysis Inhibition
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by AICAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597413:riboside [Carbohydrate]
   708   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "in some cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "in- cluding endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "has"

Phrase: "been"

Phrase: "attributed to the accumulation of ZMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0051028:ZMP [Nucleic Acid, Nucleoside, or Nucleotide]
   719   C0449234:Attribute [Idea or Concept]
   719   C1704772:Attribute [Conceptual Entity]
   719   C1882133:Attribute [Qualitative Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.213: More comprehensive investigations using constitutively active AMPK virus and dominant negative AMPK virus should resolve more definitively whether the effects of AICAR are solely due to AMPK activation. 

Phrase: "More comprehensive investigations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1261322:Investigations [Health Care Activity]
   793 E C1552578:investigation [Idea or Concept]
   743 E C1517586:Investigational [Qualitative Concept]
   743 E C3245491:investigational [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "constitutively active AMPK virus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0042736:protein virus [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0042776:Virus [Virus]
   799   C0319157:virus [Virus]

Phrase: "and"

Phrase: "dominant negative AMPK virus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0042736:protein virus [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0042776:Virus [Virus]
   799   C0319157:virus [Virus]

Phrase: "should"

Phrase: "resolve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699488:Resolve [Conceptual Entity]

Phrase: "more definitively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "whether"

Phrase: "the effects of AICAR"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "solely due to AMPK activation."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   814   C1819041:protein kinase activation [Cell Function]
   778   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0678226:Due to [Functional Concept]
           due
   774   C0599177:protein activation [Genetic Function]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1879547:Activated [Activity]
           Activation
   748   C3146286:Due [Idea or Concept]
   714 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.214: In light of the alterations in fatty-acid metabolism caused by hyperglycemia, the effect of palmitate on apoptosis has been examined in preliminary studies. 

Phrase: "In light of the alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "in fatty-acid metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596563:Fatty Acid Metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0015684:Fatty acid [Lipid]

Phrase: "caused by hyperglycemia,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020456:Hyperglycaemia [Disease or Syndrome]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "the effect of palmitate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "examined in preliminary studies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0332128:Examined [Finding]
   770   C0439611:Preliminary [Temporal Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.215: In keeping with findings in cardiomyocytes (40,45,46) and pancreatic islets (47), incubation with palmitate (0.5 mmol/l) markedly increased apoptosis in HUVEC (data not shown). 

Phrase: "In keeping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "with findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "in cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "45,"

Phrase: "46"

Phrase: ")"

Phrase: "and"

Phrase: "pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "(47"

Phrase: ")"

Phrase: ","

Phrase: "incubation with palmitate"

Phrase: "(0.5 mmol/l) markedly increased apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0162638:Apoptosis [Cell Function]
   724 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "in HUVEC"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.216: In contrast to cells incubated with 30 mmol/l glucose, this was preceded by an increase in ceramide synthesis, which, like the apoptosis, was prevented by AICAR. 

Phrase: "In contrast to cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated with 30 mmol/l glucose,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "this"

Phrase: "was"

Phrase: "preceded by an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332152:preceded [Temporal Concept]
   770   C0442805:Increase [Functional Concept]

Phrase: "in ceramide synthesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157399:ceramide synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "which,"

Phrase: "like the apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "prevented by AICAR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   753   C0597413:riboside [Carbohydrate]
   719   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.217: Similar observations have been made in cultured retinal pericytes (48). 

Phrase: "Similar observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "made in cultured retinal pericytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035298:Retinal [Body Part, Organ, or Organ Component]
   760   C0598800:Pericytes [Cell]
   726   C1881534:Make [Functional Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.218: Whether these findings reflect different metabolic mechanisms whereby hyperglycemia and palmitate cause apoptosis remains to be determined. 

Phrase: "Whether"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "different metabolic mechanisms whereby hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "palmitate cause apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.219: In this context, the contribution of ceramide to palmitate-induced apoptosis in other cell types has been questioned (49). 

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "the contribution of ceramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "to palmitate-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "in other cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "questioned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522634:Question [Intellectual Product]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.220: Furthermore, it has been shown that fatty acids that do not enhance de novo ceramide synthesis can also increase apoptosis in cultured endothelium (50). 

Phrase: "Furthermore,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that fatty acids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015684:Fatty Acids [Lipid]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "de novo ceramide synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1157399:ceramide synthesis [Molecular Function]
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]

Phrase: "can"

Phrase: "also"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "apoptosis in cultured endothelium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.221: The relevance of hyperglycemia and free fatty acidinduced apoptosis to the pathogenesis of diabetic complications is still unsettled. 

Phrase: "The relevance of hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevance [Qualitative Concept]

Phrase: "and"

Phrase: "free fatty acidinduced apoptosis to the pathogenesis of diabetic complications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0162638:Apoptosis [Cell Function]

Phrase: "is"

Phrase: "still"

Phrase: "unsettled."
Processing 00000000.tx.222: The demonstration that apoptosis increases in myocardium (4,5), vascular endothelium (5), retina (2), and neural tissues (51) of diabetic humans and experimental animals suggests that if it is not an integral event, then it is at least a marker of complications in many tissues. 

Phrase: "The demonstration"

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "increases in myocardium"
Meta Candidates (Total=10; Excluded=8; Pruned=0; Remaining=2)
   790   C0027061:Myocardium [Tissue]
   790   C0442805:Increase [Functional Concept]
   734 E C1517378:Gain [Quantitative Concept]
   718 E C1522564:Myocardial [Spatial Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "vascular endothelium"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014261:Endothelium, Vascular [Tissue]
   972 E C1706972:Blood Vessel Endothelium [Tissue]
   861   C0014257:Endothelium [Tissue]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "neural tissues"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0027757:neural tissues [Tissue]
   983 E C1762608:Neural tissue [Tissue]
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "(51"

Phrase: ")"

Phrase: "of diabetic humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Humans [Human]

Phrase: "and"

Phrase: "experimental animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0003064:experimental animal [Animal]
   861   C0003062:Animals [Animal]
   861   C1517586:Experimental [Qualitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "if"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "an integral event,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "it"

Phrase: "is at least"

Phrase: "a marker of complications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005516:Marker [Clinical Attribute]

Phrase: "in many tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.223: Of particular note is the finding of Frustaci et al. 

Phrase: "Of particular note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1316572:Note [Clinical Attribute]
   861   C1317574:Note [Intellectual Product]
   861   C1369612:Note [Clinical Attribute]

Phrase: "is"

Phrase: "the finding of Frustaci et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0037088:Finding [Sign or Symptom]
   753   C0243095:Finding [Finding]
   753   C2825141:Finding [Finding]
Processing 00000000.tx.224: (5) that apoptosis is increased by 61- and 85-fold in endothelial cells and cardiomyocytes, respectively, in ventricular myocardial biopsies obtained from diabetic humans. 

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "increased by 61-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "85-fold in endothelial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "cardiomyocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0225828:Cardiomyocytes [Cell]

Phrase: "respectively,"

Phrase: "in ventricular myocardial biopsies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1304881:Myocardial biopsy [Diagnostic Procedure]
   827   C0005558:biopsies [Diagnostic Procedure]
   793 E C0220797:biopsy [Functional Concept]

Phrase: "obtained from diabetic humans."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0086418:Humans [Human]
   770   C0241863:DIABETIC [Finding]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.225: It is interesting that they found that apoptosis in both of these cells was strongly associated with positive staining for nitrotyrosine, suggesting a correlation with oxidative stress and peroxynitrate generation. 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "that"

Phrase: "they"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that apoptosis in both of these cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162638:Apoptosis [Cell Function]

Phrase: "was"

Phrase: "strongly"

Phrase: "associated with positive staining"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0439178:% Positive [Quantitative Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C1704680:Staining [Finding]
   770   C2825490:Positive [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for nitrotyrosine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0047645:nitrotyrosine [Amino Acid, Peptide, or Protein]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a correlation with oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "peroxynitrate generation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.226: A final question raised by the present study is, "What role does AMPK play in the physiology of the normal endothelial cell?" 

Phrase: "A final question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522634:Question [Intellectual Product]

Phrase: "raised by the present study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0442818:Raised [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: ","

Phrase: """"

Phrase: "What role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "does"

Phrase: "AMPK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "play in the physiology of the normal endothelial cell?"""
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   764   C0225336:Endothelial cell [Cell]
   762   C0007613:Cell physiology [Cell Function]
   762   C0007634:Normal cell [Cell]
           Cell
   762   C1268443:Normal cell [Cell]
   762   C1325880:cell physiology [Cell Function]
   742   C0014257:Endothelial [Tissue]
   742   C0031842:Physiology [Biomedical Occupation or Discipline]
   742   C0031843:physiology [Physiologic Function]
   742   C0032214:Play [Daily or Recreational Activity]
   742   C0205307:Normal [Qualitative Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C0600138:play [Finding]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.227: Hardie and Carling (22), who first demonstrated that AMPK is regulated by changes in the AMP/ATP ratio, suggested that it serves as a fuel gauge that responds to a decrease in the energy state of a cell by increasing ATP generation (e.g., by increasing fatty-acid oxidation) and diminishing the use of ATP for certain purposes (e.g., fatty-acid synthesis). 

Phrase: "Hardie"

Phrase: "and"

Phrase: "Carling"

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "who first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "that AMPK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "regulated by changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in the AMP/ATP ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "serves as a fuel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0556991:Fuel [Manufactured Object]

Phrase: "gauge"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456564:Gauge [Spatial Concept]
  1000   C1521879:GAGE [Immunologic Factor]

Phrase: "that"

Phrase: "responds to a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "in the energy state"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0424589:Energy [Finding]
   861   C0542479:Energy [Natural Phenomenon or Process]
   861   C1301808:State [Geographic Area]
   861   C1442080:Energy [Quantitative Concept]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "of a cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "by increasing ATP generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0079411:Generation [Temporal Concept]
   827   C3146294:Generation [Activity]
   734 E C1414672:Genesis [Gene or Genome]
   734 E C2984892:Genesis [Gene or Genome]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "by increasing fatty-acid oxidation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1158366:fatty acid oxidation [Molecular Function]
   861   C0015684:Fatty acid [Lipid]
   812   C0001128:Acid [Chemical]
   812   C0030011:Oxidation [Molecular Function]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "diminishing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminishing [Quantitative Concept]

Phrase: "the use of ATP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "for certain purposes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285529:purposes [Functional Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "fatty-acid synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596562:fatty acid synthesis [Molecular Function]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   734   C0015684:Fatty acid [Lipid]

Phrase: ")."
Processing 00000000.tx.228: In keeping with this hypothesis, it has been shown that AMPK activity increases acutely in response to a variety of stresses, including postischemia hypoxia and hyperosmolarity in many cells, and in skeletal muscle in response to exercise (50,51). 

Phrase: "In keeping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "with this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that AMPK activity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   923   C1150527:protein kinase activity [Molecular Function]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   875   C1537044:protein activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "acutely in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883525:Variety [Conceptual Entity]
  1000   C2346866:Variety [Conceptual Entity]

Phrase: "of stresses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0038435:Stress [Finding]
   916 E C0231297:Stressful [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "postischemia hypoxia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242184:Hypoxia [Pathologic Function]
   861   C1963140:HYPOXIA [Finding]

Phrase: "and"

Phrase: "hyperosmolarity in many cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0259752:Hyperosmolarity [Finding]

Phrase: "and in skeletal muscle"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0242692:Muscle, Skeletal [Tissue]
   833   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   770   C0026845:Muscle [Tissue]
   770   C0037253:skeletal [Body System]
   770   C0521324:Skeletal [Spatial Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "in response to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "(50,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.229: Because AMPK seems to activate eNOS in endothelium (42) and exercising muscle (52), an interesting possibility is that it regulates the increase in endothelial cell NO generation caused by shear stress. 

Phrase: "Because"

Phrase: "AMPK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "eNOS in endothelium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   882   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   882   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   833   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0014257:Endothelial [Tissue]
   753   C0030015:oxide [Inorganic Chemical]
   753   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(42"

Phrase: ")"

Phrase: "and"

Phrase: "exercising muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026845:Muscle [Tissue]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "(52"

Phrase: ")"

Phrase: ","

Phrase: "an interesting possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "it"

Phrase: "regulates"

Phrase: "the increase in endothelial cell NO generation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "caused by shear stress."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1171318:shear stress [Natural Phenomenon or Process]
   770   C0038435:Stress [Finding]
   770   C0175735:shear [Medical Device]
   770   C0205013:shear [Therapeutic or Preventive Procedure]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.230: In addition, we have observed that AMPK in HUVEC is acutely activated by incubation in a glucose-free medium (29) and by hydrogen peroxide (Y. Ido, J. Keany, N. Ruderman, unpublished data), suggesting that it could play a role in the response of the endothelial cell to a wide variety of perturbations. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that AMPK in HUVEC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "acutely"

Phrase: "activated by incubation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "in a glucose-free medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "(29"

Phrase: ")"

Phrase: "and by hydrogen peroxide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0020275:Hydrogen [Element, Ion, or Isotope]
   770   C0031180:Peroxide [Inorganic Chemical]
   770   C0523702:HYDROGEN [Laboratory Procedure]
   770   C0885426:hydrogen [Inorganic Chemical]
   770   C1515981:And [Idea or Concept]

Phrase: "(Y. Ido,"

Phrase: "J. Keany,"

Phrase: "N. Ruderman,"

Phrase: "unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "could"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the response of the endothelial cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "to a wide variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883525:Variety [Conceptual Entity]
   861   C2346866:Variety [Conceptual Entity]

Phrase: "of perturbations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332453:perturbation [Functional Concept]
Processing 00000000.tx.231: Finally, recent studies suggest that AMPK in muscle can be activated in vivo by treatment with metformin (53) and by leptin infusion (54). 

Phrase: "Finally,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that AMPK in muscle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "in vivo by treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "with metformin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025598:Metformin [Organic Chemical,Pharmacologic Substance]

Phrase: "(53"

Phrase: ")"

Phrase: "and by leptin infusion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
   770   C0574032:Infusion [Therapeutic or Preventive Procedure]
   770   C1416825:LEPTIN [Gene or Genome]
   770   C1515981:And [Idea or Concept]
   770   C1827465:Infusion [Functional Concept]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.232: Whether similar changes occur in endothelium and, if so, what their physiological importance is remain to be determined. 

Phrase: "Whether"

Phrase: "similar changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "occur in endothelium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0014257:Endothelium [Tissue]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: ","

Phrase: "if"

Phrase: "so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "what"

Phrase: "their physiological importance"

Phrase: "is"

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.233: In conclusion, the results indicate that hyperglycemia-induced increases in TUNEL staining in cultured HUVEC are preceded by changes in intracellular fatty-acid metabolism, mitochondrial dysfunction, caspase-3 activation, and a decreased ability of insulin to activate Akt. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that hyperglycemia-induced increases in TUNEL staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:increases [Functional Concept]

Phrase: "in cultured HUVEC"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   897   C0007600:cultured cells [Cell]
   897   C0007635:Cultured Cells [Cell]
   897   C3282338:Cells, Cultured [Cell]
   875   C0427861:Human cells [Laboratory or Test Result]
   840   C0225336:Endothelial Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "preceded by changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332152:preceded [Temporal Concept]
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in intracellular fatty-acid metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0596563:Fatty Acid Metabolism [Molecular Function]
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]

Phrase: "mitochondrial dysfunction,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "caspase-3 activation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1159825:Caspase Activation [Molecular Function]
   827   C1879547:Activation [Activity]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "a decreased ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Akt."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0812228:AKT [Gene or Genome]
Processing 00000000.tx.234: They also indicate that all of these events are prevented by incubation with AICAR, which seems to act by activating AMPK. 

Phrase: "They also"

Phrase: "indicate"

Phrase: "that"

Phrase: "all of these events"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441471:Events [Event]
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   770   C3541888:Events [Classification]

Phrase: "are"

Phrase: "prevented by incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "with AICAR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597413:riboside [Carbohydrate]
   708   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "which"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act by activating AMPK."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C1879547:Activated [Activity]
           activating
   719 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.235: Additional studies are needed to establish the mechanisms responsible for these findings and their physiological relevance.  

Phrase: "Additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for these findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "their physiological relevance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevance [Qualitative Concept]
Processing 00000000.tx.236: ACKNOWLEDGMENTS  Supported in part by grant PO1-HL58854 jointly funded by the National Institutes of Health and the Juvenile Diabetes Foundation (to N.R.) and research grants from the Juvenile Diabetes Foundation (1-2000-932) and the Kilo Vascular Disease and Diabetes Foundation (to Y.I.). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "Supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by grant PO1-HL58854 jointly"

Phrase: "funded by the National Institutes of Health"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   853   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   748   C0016820:funded [Quantitative Concept]
   748   C0018684:Health [Idea or Concept]
   748   C0021622:Institutes [Organization]
   748   C3245503:national [Intellectual Product]
   714 E C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "the Juvenile Diabetes Foundation"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   734   C0011854:Juvenile Diabetes [Disease or Syndrome]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "("

Phrase: "to N.R.)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "research grants from the Juvenile Diabetes Foundation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0260206:Research Grants [Research Activity]
   748   C0018173:Grants [Quantitative Concept]
   714 E C1548284:Grant [Idea or Concept]

Phrase: "(1-2000-932"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "the Kilo Vascular Disease"
Meta Candidates (Total=17; Excluded=12; Pruned=0; Remaining=5)
   901   C0042373:Vascular disease [Disease or Syndrome]
   851 E C0018939:Blood disease NOS [Disease or Syndrome]
   851 E C1533163:Blood disease [Disease or Syndrome]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "Diabetes Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "("

Phrase: "to Y.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.237: The excellent technical assistance from Sara Farmer is greatly appreciated.  

Phrase: "The excellent technical assistance from Sara Farmer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0018896:Assistance [Social Behavior]
   748   C0449851:Technical [Functional Concept]

Phrase: "is"

Phrase: "greatly"

Phrase: "appreciated."
Processing 00000000.tx.238: FOOTNOTES  Address correspondence and reprint requests to Yasuo Ido, Boston Medical Center, EBRC 820, Diabetes and Metabolism Unit, 650 Albany St., Boston, MA 02118. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Yasuo Ido,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]

Phrase: "Boston Medical Center,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0006037:Boston [Geographic Area]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "EBRC 820,"

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "Metabolism Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "650 Albany St., Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006037:Boston [Geographic Area]

Phrase: "MA 02118."
Processing 00000000.tx.239: E-mail: yido{at}medicine.bu.edu . Received for publication 22 January 2001 and accepted in revised form 28 September 2001. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "yido{at}medicine.bu.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Received for publication 22 January 2001"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 28 September 2001."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.240: AICAR, 5-aminoimidazole-4-carboxamide-riboside; 

Phrase: "AICAR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597413:riboside [Carbohydrate]
   708   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "5-aminoimidazole-4-carboxamide-riboside"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051027:5-aminoimidazole-4-carboxamide riboside [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0597413:riboside [Carbohydrate]

Phrase: ";"
Processing 00000000.tx.241: AMPK, AMP-activated protein kinase; 

Phrase: "AMPK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "AMP-activated protein kinase"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C2350345:AMP-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           AMP-Activated Kinase
   902   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.242: DAG, diacylglycerol; 

Phrase: "DAG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043791:Diacylglycerol [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "diacylglycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043791:Diacylglycerol [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.243: eNOS, endothelial nitric oxide synthase; 

Phrase: "eNOS,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "endothelial nitric oxide synthase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0014257:Endothelial [Tissue]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ";"
Processing 00000000.tx.244: FBS, fetal bovine serum; 

Phrase: "FBS,"

Phrase: "fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.245: HUVEC, human umbilical vein endothelial cell; 

Phrase: "HUVEC,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   902   C0427861:Human cells [Laboratory or Test Result]
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "human umbilical vein endothelial cell"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   897   C0427861:human cell [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial cell [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cell [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1269647:Cell [Cell]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.246: PKC, protein kinase C; 

Phrase: "PKC,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.247: TUNEL, TdT-mediated dUTP nick-end labeling.  

Phrase: "TUNEL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600528:TUNEL [Molecular Biology Research Technique]

Phrase: "TdT-mediated dUTP nick-end labeling."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1167624:Labeling [Mental Process]
   799   C1947902:Labeling [Manufactured Object]
   799   C2827499:Labeling [Governmental or Regulatory Activity]
Processing 00000000.tx.248: REFERENCES TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Ruderman NB, Williamson JR, Brownlee M: Glucose and diabetic vascular disease. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Ruderman NB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0919442:NB [Gene or Genome]
   861   C1705347:NB [Gene or Genome]

Phrase: "Williamson JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Brownlee M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetic vascular disease."
Meta Candidates (Total=18; Excluded=12; Pruned=0; Remaining=6)
  1000   C0011875:Vascular Disease, Diabetic [Disease or Syndrome]
   901   C0042373:Vascular disease [Disease or Syndrome]
   851 E C0018939:Blood disease NOS [Disease or Syndrome]
   851 E C1533163:Blood disease [Disease or Syndrome]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]
Processing 00000000.tx.249: FASEB J 6:29052914, 1992[Abstract/Free FullText] Li W, Yanoff M, Liu X, Ye X: Retinal capillary pericyte apoptosis in early human diabetic retinopathy. 

Phrase: "FASEB J 6"

Phrase: ":"

Phrase: "29052914,"

Phrase: "1992"

Phrase: "[Abstract/Free FullText"

Phrase: "] Li W,"

Phrase: "Yanoff M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Liu X,"

Phrase: "Ye X"

Phrase: ":"

Phrase: "Retinal capillary pericyte apoptosis in early human diabetic retinopathy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.250: Chin Med J (Engl) 110:659663, 1997[Medline] Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M: Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. 

Phrase: "Chin Med J (Engl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1414400:ENGL [Gene or Genome]

Phrase: ")"

Phrase: "110"

Phrase: ":"

Phrase: "659663,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kern TS,"

Phrase: "Tang J,"

Phrase: "Mizutani M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kowluru RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Nagaraj RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Romeo G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Podesta F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lorenzi M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Response of capillary cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "to aminoguanidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282774:aminoguanidine [Organic Chemical,Pharmacologic Substance]

Phrase: "predicts"

Phrase: "the development of retinopathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: ":"

Phrase: "comparison of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "galactosemia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016952:Galactosaemia [Disease or Syndrome]
  1000   C0268151:GALACTOSEMIA [Disease or Syndrome]
Processing 00000000.tx.251: Invest Ophthalmol Vis Sci 41:39723978, 2000[Abstract/Free FullText] Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J: Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II- dependent. 

Phrase: "Invest"

Phrase: "Ophthalmol Vis Sci 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1571809:VIS [Therapeutic or Preventive Procedure]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "39723978,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fiordaliso F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Li B,"

Phrase: "Latini R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sonnenblick EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Anversa P,"

Phrase: "Leri A,"

Phrase: "Kajstura J"

Phrase: ":"

Phrase: "Myocyte death in streptozotocin-induced diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0011065:Death [Organism Function]
   753   C1306577:Death, NOS [Finding]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "is"

Phrase: "angiotensin II- dependent."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0851827:Dependent [Qualitative Concept]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]
   734   C0003009:Angiotensin 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.252: Lab Invest 80:513527, 2000[Medline] Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P: Myocardial cell death in human diabetes. 

Phrase: "Lab"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]

Phrase: "Invest"

Phrase: "80"

Phrase: ":"

Phrase: "513527,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Frustaci A,"

Phrase: "Kajstura J,"

Phrase: "Chimenti C,"

Phrase: "Jakoniuk I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Leri A,"

Phrase: "Maseri A,"

Phrase: "Nadal-Ginard B,"

Phrase: "Anversa P"

Phrase: ":"

Phrase: "Myocardial cell death in human diabetes."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007587:Cell Death [Cell Function]
   790   C0225828:Myocardial cell [Cell]
   783   C0427861:cell human [Laboratory or Test Result]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.253: Circ Res 87:11231132, 2000[Abstract/Free FullText] The effect of intensive treatment of diabetes on the development progression of long-term complications in insulin-dependent diabetes mellitus. 

Phrase: "Circ Res 87"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "11231132,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "The effect of intensive treatment of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1518681:Treatment Effect [Finding]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the development progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]

Phrase: "of long-term complications"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0009566:Complications [Pathologic Function]
   827   C1171258:complications [Pathologic Function]
   793 E C2362589:Complication [Idea or Concept]
   743 E C0231242:Complicated [Functional Concept]
   734   C0443252:Long-term [Temporal Concept]

Phrase: "in insulin-dependent diabetes mellitus."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.254: The Diabetes Control and Complications Trial Research Group. 

Phrase: "The Diabetes Control and Complications Trial Research Group."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   877   C0009932:Control Group [Group]
   795   C0441833:Group [Idea or Concept]
   795   C0687744:group [Population Group]
   795   C1257890:Group [Population Group]
   795   C1552516:Group [Health Care Related Organization]
   795   C1705428:Group [Conceptual Entity]
   795   C1705429:Group [Population Group]
Processing 00000000.tx.255: N Engl J Med 329:977986, 1993[Abstract/Free FullText] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment risk of complications in patients with type 2 diabetes (UKPDS 33). 

Phrase: "N Engl J Med 329"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "977986,"

Phrase: "1993"

Phrase: "[Abstract/Free FullText"

Phrase: "] Intensive blood-glucose control with sulphonylureas"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0005802:Blood Glucose [Carbohydrate]
   790   C0726398:GLUCOSE CONTROL [Indicator, Reagent, or Diagnostic Aid]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0229664:Blood [Body Substance]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "compared with conventional treatment risk of complications"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   800   C0679861:Complications of treatment [Pathologic Function]
           complications treatment
   778   C2945704:Conventional Treatment [Therapeutic or Preventive Procedure]
   748   C0009566:Complications [Pathologic Function]
   748   C0035647:Risk [Qualitative Concept]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C0439858:Conventional [Qualitative Concept]
   748   C1171258:complications [Pathologic Function]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C1707455:Compared [Activity]
   748   C3538994:TREATMENT [Research Activity]
   714 E C2362589:Complication [Idea or Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(UKPDS 33"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   853   C0033522:prospective study [Research Activity]
   853   C1709709:Prospective Study [Research Activity]
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C0023981:prospective [Research Activity]
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]

Phrase: ")."
Processing 00000000.tx.256: UK Prospective Diabetes Study (UKPDS) Group. 

Phrase: "UK Prospective Diabetes Study (UKPDS) Group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
Processing 00000000.tx.257: Lancet 352:837853, 1998[Medline] Implications of the United Kingdom Prospective Diabetes Study. 

Phrase: "Lancet 352"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "837853,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Implications of the United Kingdom Prospective Diabetes Study."
Processing 00000000.tx.258: American Diabetes Association. 

Phrase: "American Diabetes Association."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1705019:American Diabetes Association [Professional Society]
   827   C0004083:Association [Mental Process]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
Processing 00000000.tx.259: Diabetes Care 21:21802184, 1998[Free FullText] Laakso M: Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes. 

Phrase: "Diabetes Care 21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C1947933:Care [Activity]

Phrase: ":"

Phrase: "21802184,"

Phrase: "1998"

Phrase: "[Free FullText"

Phrase: "] Laakso M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Hyperglycemia as a risk factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "for cardiovascular disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0007222:Cardiovascular disease [Disease or Syndrome]
   861   C0007226:Cardiovascular [Body System]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.260: Prim Care 26:829839, 1999[Medline] Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhausl W: High-glucosetriggered apoptosis in cultured endothelial cells. 

Phrase: "Prim Care 26"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0331021:prim [Plant]
   827   C1947933:Care [Activity]

Phrase: ":"

Phrase: "829839,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Baumgartner-Parzer SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036154:SM [Geographic Area]

Phrase: "Wagner L,"

Phrase: "Pettermann M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Grillari J,"

Phrase: "Gessl A,"

Phrase: "Waldhausl W"

Phrase: ":"

Phrase: "High-glucosetriggered apoptosis in cultured endothelial cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C3156636:endothelial cell apoptosis [Cell Function]
   748   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.261: Diabetes 44:13231327, 1995[Abstract] Du XL, Sui GZ, Stockklauser-Farber K, Weiss J, Zink S, Schwippert B, Wu QX, Tschope D, Rosen P: Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. 

Phrase: "Diabetes 44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "13231327,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Du XL,"

Phrase: "Sui GZ,"

Phrase: "Stockklauser-Farber K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Weiss J,"

Phrase: "Zink S,"

Phrase: "Schwippert B,"

Phrase: "Wu QX,"

Phrase: "Tschope D,"

Phrase: "Rosen P"

Phrase: ":"

Phrase: "Introduction of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1293116:Introduction [Health Care Activity]
   790   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "by high proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "glucose in cultured human umbilical vein endothelial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   703   C3179121:Human Umbilical Vein Endothelial Cells [Cell]

Phrase: "is"

Phrase: "mediated by reactive oxygen species."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0205332:Reactive [Qualitative Concept]
   760   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.262: Diabetologia 41:249256, 1998[Medline] Ho FM, Liu SH, Liau CS, Huang PJ, Lin-Shiau SY: High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. 

Phrase: "Diabetologia 41"

Phrase: ":"

Phrase: "249256,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ho FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Liu SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: "Liau CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Huang PJ,"

Phrase: "Lin-Shiau SY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039138:SY [Geographic Area]
   827   C1706466:SY [Intellectual Product]

Phrase: ":"

Phrase: "High glucose-induced apoptosis in human endothelial cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   776   C3156636:endothelial cell apoptosis [Cell Function]
   744   C0162638:Apoptosis [Cell Function]

Phrase: "is"

Phrase: "mediated by sequential activations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C1548958:Sequential [Idea or Concept]
   770   C1705294:Sequential [Qualitative Concept]
   737   C1879547:Activation [Activity]

Phrase: "of c-Jun NH(2)-terminal kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   904   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   876   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   876   C1334482:Jun kinase [Gene or Genome]
   876   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   709   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "and"

Phrase: "caspase-3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.263: Circulation 101:26182624, 2000[Abstract/Free FullText] Wu QD, Wang JH, Fennessy F, Redmond HP, Bouchier-Hayes D: Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. 

Phrase: "Circulation 101"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "26182624,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wu QD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332173:QD [Temporal Concept]

Phrase: "Wang JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Fennessy F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Redmond HP,"

Phrase: "Bouchier-Hayes D"

Phrase: ":"

Phrase: "Taurine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039350:Taurine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "high-glucose-induced human vascular endothelial cell apoptosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   835   C3156636:endothelial cell apoptosis [Cell Function]
   793   C0162638:Apoptosis [Cell Function]
   721 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.264: Am J Physiol 277:C1229C1238, 1999[Abstract/Free FullText] Green DR, Reed JC: Mitochondria and apoptosis. 

Phrase: "Am"

Phrase: "J Physiol 277"

Phrase: ":"

Phrase: "C1229C1238,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Green DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Reed JC"

Phrase: ":"

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.265: Science 281:13091312, 1998[Abstract/Free FullText] Daugas E, Nochy D, Ravagnan L, Loeffler M, Susin SA, Zamzami N, Kroemer G: Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. 

Phrase: "Science 281"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "13091312,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Daugas E,"

Phrase: "Nochy D,"

Phrase: "Ravagnan L,"

Phrase: "Loeffler M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Susin SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Zamzami N,"

Phrase: "Kroemer G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Apoptosis-inducing factor (AIF)"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ":"

Phrase: "a ubiquitous mitochondrial oxidoreductase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030016:Oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1537381:oxidoreductase [Gene or Genome]

Phrase: "involved in apoptosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C1314939:Involved [Functional Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.266: FEBS Lett 476:118123, 2000[Medline] Brenner C, Kroemer G: Apoptosis: mitochondriathe death signal integrators. 

Phrase: "FEBS Lett 476"

Phrase: ":"

Phrase: "118123,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brenner C,"

Phrase: "Kroemer G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ":"

Phrase: "mitochondriathe death signal integrators."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0309311:INTEGRATOR [Amino Acid, Peptide, or Protein,Pharmacologic Substance,Vitamin]
   779   C1706057:Integrator [Medical Device]
Processing 00000000.tx.267: Science 289:11501151, 2000[Free FullText] Mallat Z, Tedgui A: Apoptosis in the vasculature: mechanisms and functional importance. 

Phrase: "Science 289"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "11501151,"

Phrase: "2000"

Phrase: "[Free FullText"

Phrase: "] Mallat Z,"

Phrase: "Tedgui A"

Phrase: ":"

Phrase: "Apoptosis in the vasculature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: ":"

Phrase: "mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "functional importance."
Processing 00000000.tx.268: Br J Pharmacol 130:947962, 2000[Abstract/Free FullText] Bertrand F, Desbois-Mouthon C, Cadoret A, Prunier C, Robin H, Capeau J, Atfi A, Cherqui G: Insulin antiapoptotic signaling involves insulin activation of the nuclear factor B-dependent survival genes encoding tumor necrosis factor receptor-associated factor 2 and manganese-superoxide dismutase. 

Phrase: "Br J Pharmacol 130"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "947962,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bertrand F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Desbois-Mouthon C,"

Phrase: "Cadoret A,"

Phrase: "Prunier C,"

Phrase: "Robin H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Capeau J,"

Phrase: "Atfi A,"

Phrase: "Cherqui G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin antiapoptotic signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "involves"

Phrase: "insulin activation of the nuclear factor B-dependent survival genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0017255:Gene Activation [Genetic Function]
   739   C1879547:Activation [Activity]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "tumor necrosis factor receptor-associated factor 2"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   927   C0255813:Tumor Necrosis Factor Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]
   927   C1363982:TUMOR NECROSIS FACTOR RECEPTOR 2 [Gene or Genome]
   927   C1447786:Tumor Necrosis Factor Receptor 2 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   877   C0077503:Tumor Necrosis Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   845   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   845   C1323304:tumor necrosis factor [Molecular Function]
   845   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C0333516:Tumor necrosis [Neoplastic Process]
   795   C0027540:Necrosis [Organ or Tissue Function]
   795   C0027651:Tumor [Neoplastic Process]
   795   C0332281:Associated [Qualitative Concept]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C1334928:Necrosis [Finding]
   795   C1521761:Factor [Functional Concept]
   795   C1578706:Tumor [Intellectual Product]
   795   C2827422:Factor [Conceptual Entity]
   795   C3273930:Tumor [Finding]
   762 E C0750490:Associate [Idea or Concept]
   762 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "manganese-superoxide dismutase."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0024708:Manganese Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0968147:Manganese Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1420307:MANGANESE SUPEROXIDE DISMUTASE [Gene or Genome]
   901   C0038838:Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0024706:Manganese [Element, Ion, or Isotope]
   827   C0038836:Superoxide [Element, Ion, or Isotope]
   827   C2348271:MANGANESE [Element, Ion, or Isotope]
Processing 00000000.tx.269: J Biol Chem 274:3059630602, 1999[Abstract/Free FullText] Dimmeler S, Hermann C, Galle J, Zeiher AM: Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3059630602,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dimmeler S,"

Phrase: "Hermann C,"

Phrase: "Galle J,"

Phrase: "Zeiher"

Phrase: "AM"

Phrase: ":"

Phrase: "Upregulation of superoxide dismutase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041904:Up-Regulation [Cell Function,Molecular Function]
   770   C0162493:Up-Regulation [Genetic Function]

Phrase: "and"

Phrase: "nitric oxide synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the apoptosis-suppressive effects of shear stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on endothelial cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.270: Arterioscler Thromb Vasc Biol 19:656664, 1999[Abstract/Free FullText] Datta SR, Brunet A, Greenberg ME: Cellular survival: a play in three Akts. 

Phrase: "Arterioscler Thromb Vasc Biol 19"

Phrase: ":"

Phrase: "656664,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Datta SR,"

Phrase: "Brunet A,"

Phrase: "Greenberg"

Phrase: "ME"

Phrase: ":"

Phrase: "Cellular survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: ":"

Phrase: "a"

Phrase: "play in three Akts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032214:Play [Daily or Recreational Activity]
   770   C0205449:Three [Quantitative Concept]
   770   C0600138:play [Finding]
Processing 00000000.tx.271: Genes Dev 13:29052927, 1999[Free FullText] Hermann C, Zeiher AM, Dimmeler S: Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase. 

Phrase: "Genes Dev 13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: ":"

Phrase: "29052927,"

Phrase: "1999"

Phrase: "[Free FullText"

Phrase: "] Hermann C,"

Phrase: "Zeiher"

Phrase: "AM"

Phrase: ","

Phrase: "Dimmeler S"

Phrase: ":"

Phrase: "Shear stress"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1171318:shear stress [Natural Phenomenon or Process]
   861   C0038435:Stress [Finding]
   861   C0175735:shear [Medical Device]
   861   C0205013:shear [Therapeutic or Preventive Procedure]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "H2O2-induced apoptosis of human endothelial cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C3156636:apoptosis of endothelial cells [Cell Function]
           endothelial cell apoptosis
   748   C0162638:Apoptosis [Cell Function]

Phrase: "by modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulation [Spatial Concept]

Phrase: "of the glutathione redox cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "nitric oxide synthase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.272: Arterioscler Thromb Vasc Biol 17:35883592, 1997[Abstract/Free FullText] Hardie DG, Carling D: The AMP-activated protein kinasefuel gauge of the mammalian cell? 

Phrase: "Arterioscler Thromb Vasc Biol 17"

Phrase: ":"

Phrase: "35883592,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hardie DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Carling D"

Phrase: ":"

Phrase: "The AMP-activated protein kinasefuel gauge of the mammalian cell?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0456564:Gauge [Spatial Concept]
   739   C1521879:GAGE [Immunologic Factor]
Processing 00000000.tx.273: Eur J Biochem 246:259273, 1997[Abstract] Stefanelli C, Stanic I, Bonavita F, Flamigni F, Pignatti C, Guarnieri C, Caldarera CM: Inhibition of glucocorticoid-induced apoptosis with 5-aminoimidazole-4-carboxamide ribonucleoside, a cell-permeable activator of AMP-activated protein kinase. 

Phrase: "Eur J Biochem 246"

Phrase: ":"

Phrase: "259273,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Stefanelli C,"

Phrase: "Stanic I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Bonavita F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Flamigni F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Pignatti C,"

Phrase: "Guarnieri C,"

Phrase: "Caldarera CM"

Phrase: ":"

Phrase: "Inhibition of glucocorticoid-induced apoptosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C1512772:Inhibition of Apoptosis [Cell Function]
           Apoptosis Inhibition
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "with 5-aminoimidazole-4-carboxamide ribonucleoside,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   888   C0051027:aminoimidazole carboxamide ribonucleoside [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0035546:Ribonucleoside [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a cell-permeable activator of AMP-activated protein kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C2247123:kinase activator [Molecular Function]
Processing 00000000.tx.274: Biochem Biophys Res Commun 243:821826, 1998[Medline] Durante P, Gueuning MA, Darville MI, Hue L, Rousseau GG: Apoptosis induced by growth factor withdrawal in fibroblasts overproducing fructose 2,6-bisphosphate. 

Phrase: "Biochem Biophys Res Commun 243"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "821826,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Durante P,"

Phrase: "Gueuning MA,"

Phrase: "Darville MI,"

Phrase: "Hue L,"

Phrase: "Rousseau GG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018370:GG [Geographic Area]

Phrase: ":"

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by growth factor withdrawal"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0205263:Induced [Functional Concept]
   760   C0220844:growth [Physiologic Function]
   760   C1521761:Factor [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2349954:Withdrawal [Activity]
   760   C2825032:Withdrawal [Mental or Behavioral Dysfunction]
   760   C2827422:Factor [Conceptual Entity]
   760   C2911660:Growth [Activity]

Phrase: "in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "overproducing"

Phrase: "fructose 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016745:Fructose [Carbohydrate,Pharmacologic Substance]

Phrase: "6-bisphosphate."
Processing 00000000.tx.275: FEBS Lett 448:239243, 1999[Medline] Ido Y, Dagher Z, Ruderman N: The AMP-activator, AICAR prevents hyperglycemia induced apoptosis in human umbilical endothelial cells (HUVEC). 

Phrase: "FEBS Lett 448"

Phrase: ":"

Phrase: "239243,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ido Y,"

Phrase: "Dagher Z,"

Phrase: "Ruderman N"

Phrase: ":"

Phrase: "The AMP-activator,"

Phrase: "AICAR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597413:riboside [Carbohydrate]
   708   C0002560:Aminoimidazole Carboxamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "apoptosis in human umbilical endothelial cells (HUVEC)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3156636:endothelial cell apoptosis [Cell Function]
   753   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.276: Diabetes 49:A140, 2000 Stein SC, Woods A, Jones NA, Davison MD, Carling D: The regulation of AMP-activated protein kinase by phosphorylation. 

Phrase: "Diabetes 49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "A140,"

Phrase: "2000 Stein SC,"

Phrase: "Woods A,"

Phrase: "Jones NA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1272460:{NA} [Qualitative Concept]

Phrase: "Davison MD,"

Phrase: "Carling D"

Phrase: ":"

Phrase: "The regulation of AMP-activated protein kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "by phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.277: Biochem J 345(Pt. 

Phrase: "Biochem J 345"

Phrase: "(Pt."
Processing 00000000.tx.278: 3):437443, 2000 Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferre P, Foufelle F, Carling D: Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ":"

Phrase: "437443,"

Phrase: "2000 Woods A,"

Phrase: "Azzout-Marniche D,"

Phrase: "Foretz M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Stein SC,"

Phrase: "Lemarchand P,"

Phrase: "Ferre P,"

Phrase: "Foufelle F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Carling D"

Phrase: ":"

Phrase: "Characterization of the role of AMP-activated protein kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of glucose-activated gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0017262:Gene Expression [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "constitutively active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]

Phrase: "and"

Phrase: "dominant negative forms of the kinase."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0205160:Negative [Qualitative Concept]
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   719 E C1522492:Form [Functional Concept]
Processing 00000000.tx.279: Mol Cell Biol 20:67046711, 2000[Abstract/Free FullText] Dagher Z, Ruderman N, Tornheim K, Ido Y: The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells. 

Phrase: "Mol Cell Biol 20"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "67046711,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dagher Z,"

Phrase: "Ruderman N,"

Phrase: "Tornheim K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ido Y"

Phrase: ":"

Phrase: "The effect of AMP-activated protein kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "its activator AICAR on the metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0597413:riboside [Carbohydrate]

Phrase: "of human umbilical vein endothelial cells."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
  1000   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
   897   C0427861:Human cells [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial Cells [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.280: Biochem Biophys Res Commun 265:112115, 1999[Medline] Dagher Z, Ruderman N, Tornheim K, Ido Y: Acute regulation of fatty acid oxidation and AMP-activated protein kinase in human umbilical vein endothelial cells. 

Phrase: "Biochem Biophys Res Commun 265"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "112115,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dagher Z,"

Phrase: "Ruderman N,"

Phrase: "Tornheim K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ido Y"

Phrase: ":"

Phrase: "Acute regulation of fatty acid oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   938   C1158369:regulation of fatty acid oxidation [Cell Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "AMP-activated protein kinase in human umbilical vein endothelial cells."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C2350345:AMP-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           AMP-Activated Kinase
   760   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1879547:Activated [Activity]
   706 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.281: Circ Res 88:12761282, 2001[Abstract/Free FullText] Zhang H, Bolton TB, Piekarska AE, McPherson GA: The electrophysiological effects of tetraphenylphosphonium on vascular smooth muscle. 

Phrase: "Circ Res 88"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "12761282,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhang H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Bolton TB,"

Phrase: "Piekarska AE,"

Phrase: "McPherson GA"

Phrase: ":"

Phrase: "The electrophysiological effects of tetraphenylphosphonium"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on vascular smooth muscle."
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
  1000   C0026844:Muscle, Smooth, Vascular [Tissue]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   755 E C0442025:Muscular [Spatial Concept]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]
Processing 00000000.tx.282: Eur J Pharmacol 347:119123, 1998[Medline] Van Veldhoven PP, Bishop WR, Yurivich DA, Bell RM: Ceramide quantitation: evaluation of a mixed micellar assay using E. coli diacylglycerol kinase. 

Phrase: "Eur J Pharmacol 347"

Phrase: ":"

Phrase: "119123,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Van Veldhoven PP,"

Phrase: "Bishop WR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420193:WR [Gene or Genome]
   861   C1425679:WR [Gene or Genome]
   861   C1862190:WR [Immunologic Factor]
   861   C3538902:WR [Gene or Genome]

Phrase: "Yurivich DA,"

Phrase: "Bell RM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: ":"

Phrase: "Ceramide quantitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709793:Quantitation [Quantitative Concept]

Phrase: ":"

Phrase: "evaluation of a mixed micellar assay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "E. coli diacylglycerol kinase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0113519:Diacylglycerol Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0043791:Diacylglycerol [Biologically Active Substance,Lipid,Pharmacologic Substance]
Processing 00000000.tx.283: Biochem Mol Biol Int 36:2130, 1995[Medline] Foester E, Lynen F. 

Phrase: "Biochem Mol Biol Int 36"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   804   C0027960:Mole [Neoplastic Process]
   804   C0063789:INT [Organic Chemical]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1456781:mole [Neoplastic Process]
   804   C1824986:mol [Gene or Genome]
   804   C3272375:INT [Intellectual Product]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "2130,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Foester E,"

Phrase: "Lynen F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.284: Malonyl Coenzyme A: Radiometric Method 3rd Ed. 

Phrase: "Malonyl Coenzyme A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024645:Malonyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: ":"

Phrase: "Radiometric Method 3rd Ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3538926:ED [Idea or Concept]
Processing 00000000.tx.285: New York, VCH Verlagsgesellschaft, 1987 Karam GA, Arslanian MJ: A rapid method for the purification of fatty acid synthetase from the yeast Saccharomyces cerevisiae. 

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "VCH Verlagsgesellschaft,"

Phrase: "1987 Karam GA,"

Phrase: "Arslanian MJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: ":"

Phrase: "A rapid method for the purification of fatty acid synthetase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0872257:rapid method [Diagnostic Procedure]
   739   C0025663:Method [Intellectual Product]
   739   C0449851:Method [Functional Concept]
   739   C0871511:METHOD [Intellectual Product]

Phrase: "from the yeast Saccharomyces cerevisiae."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036025:Saccharomyces cerevisae [Fungus]
   827   C0036024:Saccharomyces [Fungus]
Processing 00000000.tx.286: Int J Biochem 16:667673, 1984[Medline] Jung F, Haendeler J, Goebel C, Zeiher AM, Dimmeler S: Growth factor-induced phosphoinositide 3-OH kinase/Akt phosphorylation in smooth muscle cells: induction of cell proliferation and inhibition of cell death. 

Phrase: "Int J Biochem 16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0063789:INT [Organic Chemical]
   812   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "667673,"

Phrase: "1984"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jung F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Haendeler J,"

Phrase: "Goebel C,"

Phrase: "Zeiher"

Phrase: "AM"

Phrase: ","

Phrase: "Dimmeler S"

Phrase: ":"

Phrase: "Growth factor-induced phosphoinositide 3-OH kinase/Akt phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   854   C3272102:phosphoinositide phosphorylation [Molecular Function]
   791   C0031715:Phosphorylation [Molecular Function]
   791   C1158886:Phosphorylation [Molecular Function]

Phrase: "in smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C1135918:Smooth Muscle Cells [Cell]
   901   C0596981:Muscle Cells [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cells [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: ":"

Phrase: "induction of cell proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "inhibition of cell death."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C1516339:Cell Death Inhibition [Cell Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.287: Cardiovasc Res 48:148157, 2000[Medline] Inoguchi T, Xia P, Kunisaki M, Higashi S, Feener EP, King GL: Insulins effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. 

Phrase: "Cardiovasc Res 48"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "148157,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Inoguchi T,"

Phrase: "Xia P,"

Phrase: "Kunisaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Higashi S,"

Phrase: "Feener EP,"

Phrase: "King"

Phrase: "GL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: ":"

Phrase: "Insulins effect on protein kinase C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "diacylglycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043791:Diacylglycerol [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "induced by diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0205263:Induced [Functional Concept]

Phrase: "and"

Phrase: "glucose in vascular tissues."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   769   C0005802:Blood Glucose [Carbohydrate]
Processing 00000000.tx.288: Am J Physiol 267:E369E379, 1994[Abstract/Free FullText] Pillay TS, Xiao S, Olefsky JM: Glucose-induced phosphorylation of the insulin receptor: functional effects and characterization of phosphorylation sites. 

Phrase: "Am"

Phrase: "J Physiol 267"

Phrase: ":"

Phrase: "E369E379,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pillay TS,"

Phrase: "Xiao S,"

Phrase: "Olefsky JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: ":"

Phrase: "Glucose-induced phosphorylation of the insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: ":"

Phrase: "functional effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "characterization of phosphorylation sites."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]
Processing 00000000.tx.289: J Clin Invest 97:613620, 1996[Abstract/Free FullText] Matthaei S, Stumvoll M, Kellerer M, Haring HU: Pathophysiology and pharmacological treatment of insulin resistance. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "613620,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Matthaei S,"

Phrase: "Stumvoll M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kellerer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Haring"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0242372:haring [Mammal]
   966 E C1425660:HARE [Gene or Genome]

Phrase: "HU"

Phrase: ":"

Phrase: "Pathophysiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031847:pathophysiology [Functional Concept]
  1000   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "and"

Phrase: "pharmacological treatment of insulin resistance."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0013216:Pharmacological Treatment [Therapeutic or Preventive Procedure]
   797   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.290: Endocr Rev 21:585618, 2000[Abstract/Free FullText] Lin Y, Itani SI, Kurowski TG, Dean DJ, Luo Z, Yaney GC, Ruderman NB: Inhibition of insulin signaling and glycogen synthesis by phorbol dibutyrate in rat skeletal muscle. 

Phrase: "Endocr Rev 21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "585618,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lin Y,"

Phrase: "Itani SI,"

Phrase: "Kurowski TG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337445:TG [Laboratory Procedure]

Phrase: "Dean DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Luo Z,"

Phrase: "Yaney GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Ruderman NB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0919442:NB [Gene or Genome]
   861   C1705347:NB [Gene or Genome]

Phrase: ":"

Phrase: "Inhibition of insulin signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "glycogen synthesis by phorbol dibutyrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1157202:glycogen synthesis [Molecular Function]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "in rat skeletal muscle."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.291: Am J Physiol Endocrinol Metab 281:E8E15, 2001[Abstract/Free FullText] Paumen MB, Ishida Y, Muramatsu M, Yamamoto M, Honjo T: Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 281"

Phrase: ":"

Phrase: "E8E15,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Paumen MB,"

Phrase: "Ishida Y,"

Phrase: "Muramatsu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yamamoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Honjo T"

Phrase: ":"

Phrase: "Inhibition of carnitine palmitoyltransferase I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "sphingolipid synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157397:sphingolipid synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "palmitate-induced apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.292: J Biol Chem 272:33243329, 1997[Abstract/Free FullText] Hickson-Bick DL, Buja ML, McMillin JB: Palmitate-mediated alterations in the fatty acid metabolism of rat neonatal cardiac myocytes. 

Phrase: "J Biol Chem 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "33243329,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hickson-Bick DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642216:/dL [Quantitative Concept]

Phrase: "Buja ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "McMillin JB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: ":"

Phrase: "Palmitate-mediated alterations in the fatty acid metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1515926:Alteration [Idea or Concept]

Phrase: "of rat neonatal cardiac myocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0225828:Myocytes, Cardiac [Cell]
   812   C0596981:Myocytes [Cell]
Processing 00000000.tx.293: J Mol Cell Cardiol 32:511519, 2000[Medline] Blazquez C, Geelen MJ, Velasco G, Guzman M: The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes. 

Phrase: "J Mol Cell Cardiol 32"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   840   C2346604:J/mol [Quantitative Concept]
   804   C0007634:Cell [Cell]
   804   C0027960:Mole [Neoplastic Process]
   804   C0324740:Mole [Mammal]
   804   C0439189:Mole [Quantitative Concept]
   804   C1269647:Cell [Cell]
   804   C1456781:mole [Neoplastic Process]
   804   C1704653:Cell [Medical Device]
   804   C1824986:mol [Gene or Genome]
   804   C1948049:Cell [Spatial Concept]
   721 E C0026367:Molar [Body Part, Organ, or Organ Component]
   704 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "511519,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Blazquez C,"

Phrase: "Geelen MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Velasco G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Guzman M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "The AMP-activated protein kinase"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C2350345:AMP-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           AMP-Activated Kinase
   902   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "ceramide synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157399:ceramide synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "de novo"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1515568:de novo [Idea or Concept]
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "and"

Phrase: "apoptosis in astrocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.294: FEBS Lett 489:149153, 2001[Medline] Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE: AMP-activated protein kinase phosphorylation of endothelial NO synthase. 

Phrase: "FEBS Lett 489"

Phrase: ":"

Phrase: "149153,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chen ZP,"

Phrase: "Mitchelhill KI,"

Phrase: "Michell BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Stapleton D,"

Phrase: "Rodriguez-Crespo I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Witters LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Power DA,"

Phrase: "Ortiz de Montellano PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0279759:PR+ [Laboratory or Test Result]
   812   C0279766:PR- [Laboratory or Test Result]
   812   C1418864:PR@ [Gene or Genome]
   812   C3538934:PR [Intellectual Product]
   812   C3538935:PR [Idea or Concept]

Phrase: "Kemp"

Phrase: "BE"

Phrase: ":"

Phrase: "AMP-activated protein kinase phosphorylation of endothelial NO synthase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1157225:AMP phosphorylation [Molecular Function]
   762   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   742   C0031715:Phosphorylation [Molecular Function]
Processing 00000000.tx.295: FEBS Lett 443:285289, 1999[Medline] Dimmeler S, Assmus B, Hermann C, Haendeler J, Zeiher AM: Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. 

Phrase: "FEBS Lett 443"

Phrase: ":"

Phrase: "285289,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dimmeler S,"

Phrase: "Assmus B,"

Phrase: "Hermann C,"

Phrase: "Haendeler J,"

Phrase: "Zeiher"

Phrase: "AM"

Phrase: ":"

Phrase: "Fluid shear stress"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C1171318:shear stress [Natural Phenomenon or Process]
   827   C0038435:Stress [Finding]
   827   C0175735:shear [Medical Device]
   827   C0205013:shear [Therapeutic or Preventive Procedure]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "stimulates"

Phrase: "phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "in human endothelial cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C0225336:Endothelial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0086418:Human [Human]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "involvement in suppression of apoptosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.296: Circ Res 83:334341, 1998[Abstract/Free FullText] Javaux F, Vincent MF, Wagner DR, van den Berghe G: Cell-type specificity of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside: lack of effect in rabbit cardiomyocytes and human erythrocytes, and inhibition in FTO-2B rat hepatoma cells. 

Phrase: "Circ Res 83"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "334341,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Javaux F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Vincent MF,"

Phrase: "Wagner DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "van den Berghe G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Cell-type specificity of inhibition of glycolysis"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0449475:Type of cell [Intellectual Product]
           cell type
   778   C0007634:Cell Type [Cell]
           Cell
   748   C0037791:Specificity [Quantitative Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1511884:Specificity [Quantitative Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "by 5-amino-4-imidazolecarboxamide riboside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0597413:riboside [Carbohydrate]

Phrase: ":"

Phrase: "lack of effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332268:lack [Qualitative Concept]

Phrase: "in rabbit cardiomyocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0225828:Cardiomyocytes [Cell]

Phrase: "and"

Phrase: "human erythrocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "and"

Phrase: "inhibition in FTO-2B rat hepatoma cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]
Processing 00000000.tx.297: Biochem J 305:913919, 1995[Medline] de Vries JE, Vork MM, Roemen TH, de Jong YF, Cleutjens JP, van der Vusse GJ, van Bilsen M: Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. 

Phrase: "Biochem J 305"

Phrase: ":"

Phrase: "913919,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] de Vries JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0454673:JE [Geographic Area]
   827   C1550752:JE [Temporal Concept]

Phrase: "Vork MM,"

Phrase: "Roemen TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "de Jong YF,"

Phrase: "Cleutjens JP,"

Phrase: "van der Vusse GJ,"

Phrase: "van Bilsen M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Saturated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522534:Saturated [Phenomenon or Process]
  1000   C1705188:SATURATED [Quantitative Concept]

Phrase: "but"

Phrase: "not mono-unsaturated fatty acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0015690:Fatty Acids, Unsaturated [Lipid]
   840   C0015684:Fatty Acids [Lipid]
   804   C0001128:Acids [Chemical]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptotic cell death in neonatal rat ventricular myocytes."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0162638:apoptotic cell death [Cell Function]
   770   C0007587:Cell Death [Cell Function]
   767   C0410916:Neonatal death [Pathologic Function]
   744   C0007634:Cell [Cell]
   744   C0011065:Death [Organism Function]
   744   C1269647:Cell [Cell]
   744   C1306577:Death, NOS [Finding]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.298: J Lipid Res 38:13841394, 1997[Abstract] Sparagna GC, Hickson-Bick DL, Buja LM, McMillin JB: A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. 

Phrase: "J Lipid Res 38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023779:Lipid [Lipid]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "13841394,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sparagna GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Hickson-Bick DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642216:/dL [Quantitative Concept]

Phrase: "Buja LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "McMillin JB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: ":"

Phrase: "A metabolic role for mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in palmitate-induced cardiac myocyte apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0162638:Apoptosis [Cell Function]
   733 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.299: Am J Physiol Heart Circ Physiol 279:H2124H2132, 2000[Abstract/Free FullText] Shimabukuro M, Zhou YT, Levi M, Unger RH: Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. 

Phrase: "Am"

Phrase: "J Physiol Heart Circ Physiol 279"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0332520:Circ [Quantitative Concept]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]
   799   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "H2124H2132,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimabukuro M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zhou YT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412122:YT [Gene or Genome]

Phrase: "Levi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Unger RH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: ":"

Phrase: "Fatty acid-induced beta cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0162638:Apoptosis [Cell Function]
   727 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ":"

Phrase: "a link between obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.300: Proc Natl Acad Sci U S A 95:24982502, 1998[Abstract/Free FullText] Ido Y, Alexios A, Dagher Z, Ruderman N: Synergistic effects of glucose and fatty acid in causing apoptosis in retinal pericytes. 

Phrase: "Proc Natl Acad Sci U S A 95"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "24982502,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ido Y,"

Phrase: "Alexios A,"

Phrase: "Dagher Z,"

Phrase: "Ruderman N"

Phrase: ":"

Phrase: "Synergistic effects of glucose"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C1158774:glucose effect [Genetic Function]
   770   C1280500:effects [Qualitative Concept]
   770   C2986495:Synergistic [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "fatty acid in causing apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0015684:Fatty acid [Lipid]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]

Phrase: "in retinal pericytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598800:Pericytes [Cell]
Processing 00000000.tx.301: Diabetes 50 (Suppl. 2):A193, 2001 Listenberger LL, Ory DS, Schaffer JE: Palmitate-induced apoptosis can occur through a ceramide-independent pathway. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Suppl. 2"

Phrase: ")"

Phrase: ":"

Phrase: "A193,"

Phrase: "2001 Listenberger LL,"

Phrase: "Ory DS,"

Phrase: "Schaffer JE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: ":"

Phrase: "Palmitate-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "can"

Phrase: "occur through a ceramide-independent pathway."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007745:Ceramide [Biologically Active Substance,Lipid]
   753   C0085862:Independent [Idea or Concept]
   753   C1299583:Independent [Finding]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.302: J Biol Chem 276:1489014895, 2001[Abstract/Free FullText] Artwohl M, Roden M, Freudenthaler A, Waldhausl W, Baum-Gartner-Parzer S: Modulation by free fatty acids of endothelial apoptosis and proliferation. 

Phrase: "J Biol Chem 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1489014895,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Artwohl M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Roden M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Freudenthaler A,"

Phrase: "Waldhausl W,"

Phrase: "Baum-Gartner-Parzer S"

Phrase: ":"

Phrase: "Modulation by free fatty acids of endothelial apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443264:Modulation [Spatial Concept]

Phrase: "and"

Phrase: "proliferation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.303: Diabetes 50 (Suppl. 2):A140, 2001 Greene DA, Stevens MJ, Obrosova I, Feldman EL: Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Suppl. 2"

Phrase: ")"

Phrase: ":"

Phrase: "A140,"

Phrase: "2001 Greene DA,"

Phrase: "Stevens MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Obrosova I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Feldman EL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]

Phrase: ":"

Phrase: "Glucose-induced oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   812   C0038435:Stress [Finding]
   812   C0311404:Oxidative [Functional Concept]
   741 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "programmed cell death in diabetic neuropathy."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0162638:Programmed Cell Death [Cell Function]
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.304: Eur J Pharmacol 375:217223, 1999[Medline] Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, Kemp BE: AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. 

Phrase: "Eur J Pharmacol 375"

Phrase: ":"

Phrase: "217223,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chen ZP,"

Phrase: "McConell GK,"

Phrase: "Michell BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Snow RJ,"

Phrase: "Canny BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Kemp"

Phrase: "BE"

Phrase: ":"

Phrase: "AMPK signaling in contracting human skeletal muscle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0037083:Signaling [Cell Function]
   742   C3537152:signaling [Biologic Function]

Phrase: ":"

Phrase: "acetyl-CoA carboxylase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001022:Acetyl-CoA Carboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0007064:Carboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "NO synthase phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0132555:NO Synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.305: Am J Physiol Endocrinol Metab 279:E1202E1206, 2000[Abstract/Free FullText] Zhou G, Ying L, Chen Y, Shen X, Doebber T, Moller D: AMP-kinase mediates metabolic effects of metformin. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 279"

Phrase: ":"

Phrase: "E1202E1206,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhou G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ying L,"

Phrase: "Chen Y,"

Phrase: "Shen X,"

Phrase: "Doebber T,"

Phrase: "Moller D"

Phrase: ":"

Phrase: "AMP-kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "metabolic effects of metformin."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C2945675:metabolic effects [Physiologic Function]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.306: Diabetes 50 (Suppl. 2):A274, 2001 Minokoshi Y, Kim Y, Muller C, Carling D, Kahn B: Leptin activates 5'-AMP-activated protein kinase and suppress acetyl CoA carboxylase. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Suppl. 2"

Phrase: ")"

Phrase: ":"

Phrase: "A274,"

Phrase: "2001 Minokoshi Y,"

Phrase: "Kim Y,"

Phrase: "Muller C,"

Phrase: "Carling D,"

Phrase: "Kahn B"

Phrase: ":"

Phrase: "Leptin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1416825:LEPTIN [Gene or Genome]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "5'-AMP-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C2350345:5'-AMP-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           AMP-Activated Protein Kinase
           AMP-Activated Kinase
   875   C0001497:AMP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "acetyl CoA carboxylase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001022:Acetyl-CoA Carboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0007064:Carboxylase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.307: Diabetes 50 (Suppl. 2):A14, 2001

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Suppl. 2"

Phrase: ")"

Phrase: ":"

Phrase: "A14,"

Phrase: "2001"

